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The roles of the intergenic sequences (IGS) and untranslated regions (UTR) in Newcastle 
disease virus (NDV) transcription and pathogenesis are not clear. By our established reverse 
genetics system, we investigated the role of these noncoding regions in NDV life cycle.  
The infectious recombinant viruses containing increased/decreased length of F-HN and 
HN-L IGS were recovered and the transcription and pathogenicity of mutants were 
characterized. Our studies indicated that increased F-HN or HN-L IGS length reduced the 
downstream gene transcription. Morever, all IGS mutants were attenuated in chickens and the 
level of attenuation was increased as the length of IGS increased. 
The mutant viruses with modified 5’ and 3’ UTR of HN mRNA were also recovered. The 
transcription, translation and pathogenecity of these recombinant viruses were characterized. Our 
studies indicated that the UTRs are not essential for NDV replication in vitro. Complete 
deletions of 5’ HN UTR down regulated its transcription, translation levels and incorporation of 
HN protein into virus particle, therefore, attenuated  the pathogenicity of NDV in chickens. 
  
Moreover, studies on the HN UTRs replaced with corresponding NP UTRs virus suggested that 
UTRs can be exchanged between NDV mRNAs without affecting the replication of virus in vitro 
and in vivo. 
In summary, my research identifies for the first time the role of noncoding regions in 
NDV replication and pathogenesis and provides novel methods for the development of 
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Newcastle disease is a highly contagious fatal disease in chickens that affects many 
domestic and wild avian species, causing severe economic losses to the poultry industry in the 
world. The infected birds may develop respiratory signs, like nasal discharge, coughing and 
sneezing, or nervous signs, like lameness, circling and complete paralysis. In some cases, sudden 
death occurs without any clinic signs. 
In the United States, the virulent form of the disease is known as Exotic Newcastle 
disease (END). There were several END outbreaks in the US recently. In 1971, a major outbreak 
occurred in Southern California and almost 12 million birds were destroyed 
(http://www.lapublichealth.org/vet/newcastle.htm). This outbreak threatened the nation’s entire 
poultry and egg supply. The most recent END outbreak was reported in California during 2002 
to 2003. This outbreak, which first occurred in a small flock of backyard birds, resulted from 
illegal importation of game birds and later spread to commercial poultry. During this outbreak, 4 
million birds were destroyed at a lost of $160 million dollars (Pedersen et al., 2004; Nolen, 2003 
a&b).  
The causative agent, Newcastle disease virus (NDV), is a member of the genus Avulavirus 




on severity of the disease produced in chickens. Avirulent, intermediate virulent and highly 
virulent strains are termed as lentogenic, mesogenic and velogenic strains, respectively. 
Lentogenic strains, such as LaSota, B1, Ulster, D26, may only cause mild or inapparent 
respiratory disease. Some lentogenic strains, such as LaSota and B1, are usually used as live 
vaccines in the field. Mesogenic strains, such as Kimber, Roakin and Beaudette C, cause 
respiratory or nervous signs with moderate mortality. Velogenic strains cause severe intestinal 
and/or neurologic disease resulting in up to 100% mortality. The velogenic strains can be further 
classified into neurotropic, such as Cormorant, AV and Texas GB, and viscerotropic, such as 
Herts, Milano and Fontana. 
The genome of NDV is a nonsegmented, single-stranded, negative-sense RNA of 15,186 
nucleotides (nt). The genome contains six genes,  encoding the nucleocaspid protein (NP), 
phosphoprotein (P), matrix protein (M), fusion protein (F), hemagglutinin-neuraminidase protein 
(HN), and large RNA-dependent RNA polymerase protein (L). Two additional proteins, V and 
W, may be produced by RNA editing during P gene transcription. The RNA genome is tightly 
encapsidated by the NP protein. This ribonucleoprotein (RNP) complex serves as the template for 
transcription and replication by viral RNA polymerase proteins, which are L and P proteins. The 
NDV genes are arranged on genomic RNA in the order 3’-NP-P-M-F-HN-L-5’. Flanking the 
genes are 3’ and 5’ extracistronic sequences, known as the leader and trailer, respectively. These 
leader and trailer regions are cis-acting regulatory elements involved in transcription, replication, 
and packaging of the genomic and antigenomic RNAs.  The beginning and end of each gene are 
conserved transcriptional control sequences, known as gene start (GS) and gene end (GE), 
respectively. Between the gene boundaries are non-coding intergenic sequences (IGSs), which 




each gene ORF and GE, there are untranslated regions (UTRs). These UTRs are not conserved in 
sequence composition and length between each gene and also vary among NDV strains. The 
functions of viral proteins coding sequences are well known, but very little is known about the 
function of noncoding regions. For example, the role of IGS and UTR in NDV transcription, 
replication, and pathogenesis remains unknown. Therefore, in this study, we have examined the 
role of IGS and UTR in the NDV life cycle using reverse genetics. 
 
1.3 Research objectives: 
 
(1) Determine the role of IGS in NDV transcription and pathogenesis.   
Infectious recombinant viruses were constructed that contained deletion/addition of 
nucleotides into IGS between F-HN and/or HN-L. The transcription, replication, and 
pathogenicity of these viruses were examined in chickens. 
(2) Analyses the role of UTR in NDV transcription, replication and pathogenesis.  
Several recombinant viruses were constructed that contained deletion/modification in the 
UTR of HN mRNA. These mutant viruses were examined for their in vitro replication 




















Review of Literature 
 
2.2 Classification 
Newcastle Disease virus (NDV) is a member of the genus Avulavirus in the family 
Paramyxoviridae of the order Mononegavirales (de Leeuw et al., 1999). The family 
Paramyxoviridae is divided into two subfamilies: Paramyxovirinae and Pneumovirinae. The 
subfamily Paramyxovirinae is further subdivided into five genera: Avulavirus, Henipavirus, 
Morbillivirus, Respirovirus and Rubulavirus. The genus Avulavirus contains nine serotypes of 
avian paramyxoviruses (APMV-1-9). NDV represents type 1(APMV-1). Besides NDV, the 
family Paramyxovirudae includes other important animal pathogens such as rinderpest virus and 
bovine respiratory syncytial virus, and some human pathogens such as mumps virus and measles 
virus. 
 
 2.3 Viral Morphology 
The typical NDV is a pleomorphic, enveloped particle with diameter between 100-300nm 
(Shnyrova et al., 2007) (Fig.2.1). The envelope of NDV is derived from host cell membrane. 




like protrusions on the outer surface of the virions. The F protein is required for fusion of virion 
into the host cell membrane through pH-independent mechanism. The HN protein is responsible 
for attachment of the virus to host cell. Under the envelope is a Matrix protein, which is thought 
to play a major role in mature virus budding. Inside the envelope is the ribo-nucleocapsid core 
structure which is the template for virus RNA synthesis. The core structure is formed by 
nucleocapsid protein (NP) tightly bound to the genomic RNA, to which phosphoprotein (P) and 
large polymerase protein (L) are attached.  
 
2.4 Genome 
The genome of NDV is a nonsegmented, single-stranded, and negative sense RNA of 
15,186 nucleotides (nt) in length (Fig.2.2). The genome contains six genes: nucleocaspid protein 
(NP) gene, phosphoprotein (P) gene, matrix protein (M) gene, fusion protein (F) gene, 
hemagglutinin neuramindase protein (HN) gene, and large RNA-dependent RNA polymerase 
protein (L) gene. These genes are arranged in a linear order 3’-NP-P-M-F-HN-L-5’. The RNA 
genome and antigenome are tightly encapsidated by the NP protein. Flanking the genome are 3’ 
and 5’ extracistronic sequences, known as the leader and trailer, respectively. These leader and 
trailer regions are cis-acting regulatory elements involved in replication, transcription and 
packaging of the genomic and antigenomic RNAs.  The beginning and end of each gene are 
conserved transcriptional control sequences, known as the gene start (GS) and gene end (GE), 
respectively. Between the gene boundaries are non-coding intergenic sequences (IGS), which 
vary in length from 1 to 47 nt. Each mRNA or open reading frame (ORF) is flanked by 5’ and 3’ 











FIG.2.1 Schemtic of Newcastle disease virus particle. 
The F and HN proteins form spike-like instruments on the virion envelope. The M protein is 
under the envelope. Insider envelope the NP protein is tightly bound to genome RNA, forming 
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FIG.2.2 Genetic map of genome RNA of NDV. 
The single-stranded, negative-sense genome RNA is 15,186 nt. in length. The length of leader, 
trailer is shown in parentheses. Each gene is flanked by conserved gene start and gene end. 















 2.5 Viral proteins 
The genome of NDV encodes six major structural proteins: nucleocaspid protein (NP), 
phosphoprotein (P), matrix protein (M), fusion protein (F), hemagglutinin neuraminidase protein 
(HN), and large RNA-dependent RNA polymerase protein (L). Two more proteins W and V are 
produced by P gene editing during mRNA transcription. The genome RNA together with NP, P, 
and L proteins forms the ribonucleoprotein complex (RNP), which serves as the template for 
RNA transcription and replication. On the envelope, two membrane glycoproteins, HN and F 
proteins, form the spike-like protrusions. 
 
2.5.1 Ribonucleoprotein complex 
 
 The RNA genome of NDV is tightly encapsidated by the NP protein to form the NP: RNA 
complex which serves as the template for transcription and replication. Together with P and L 
proteins, NP: RNA complex is the minimal transcription unit (Hamagachi et al., 1983). 
NP protein:  The NP protein of NDV is 489 amino acids long and is highly conserved. 
The molecular weight of NP is around 54 kilodaltons (kD) (Samson et al., 1988). The genome 
and antigenome of paramyxoviruses are never found as free RNA instead they are tightly 
associated with the viral NP protein to form a ribonucleoprotein core. This core structure severs 
as the transcription and replication template. The level of unbounded NP protein is the key factor 
to control the switch of genome from transcription to replication.  The NP protein regulates 
transcription and replication of the viral genome by interacting with P alone, with P and L, or 




immunogenic in nature and has been used as antigens for diagnostic purposes (Errington et al., 
1995).   
Phosphoprotein:  The molecular weight of P protein is 53-56 kD (Samson et al., 1988). 
The amino terminus of the P protein acts as a chaperone for preventing uncontrolled 
encapsidation of non-viral RNA by NP protein (Curran et al., 1995; Errington et al., 1997). Like 
other paramyxoviruses, P gene mRNA of NDV has been modified during transcription by the 
addition of nontemplated G residues at position 484; as a result, two additional viral proteins, V 
and W, are produced from alternative ORF within the P gene during RNA transcription (Steward 
et al., 1993). 
Large polymerase protein: The L gene is 6704 nt long and the predicted molecular mass 
of the polypeptide is 242 kD (Yusoff et al., 1987). The L protein is the largest viral protein and 
contains all the catalytic activities associated with the viral RNA dependent RNA polymerase 
(Lamb and Parks, 2007). In the virions, the L protein is the least abundant of the structural 
proteins (about 50 copies per virion). The L protein is responsible for capping and 
polyadenylation of mRNAs. L protein of NDV is a determinant of virulence (Rout and Samal, 
2008). 
 
2.5.2 Matrix protein 
 
 The M gene of NDV is 1241 nt long and its predicted molecular mass is 38-40 kD 
(Chamber et al., 1986; Samson et al., 1988). The M protein is the most abundant protein in the 
virion and is under the envelop serving as a bridge to interact with the cytoplasmic tails of the 
integral membrane proteins, the lipid bilayer and the nucleocapsid. The M protein is considered to 




to interact with the nucleocapsid is the driving force in forming a budding virus particle (Peeples, 
1991).  
  
2.5.3 Membrane glycoproteins 
 
The envelope of NDV virions contains two transmembrane glycoproteins, HN and F. 
They form spike-like protrusions on the outer surface of the virions. The F protein exists on the 
surfaces of virions and infected cells as a homotrimeric spike, whereas the HN protein exists as a 
tetrameric spike (Russell et al., 1994; Thompson et al., 1988; Melanson and Iorio, 2006; Mirza et 
al., 1993). F protein of NDV requires the presence of the HN protein for the fusion activity 
(Sergel et al., 1993). 
Fusion protein:   Like other paramyxovirus F proteins, the F protein of NDV is a type I 
membrane protein. It is synthesized as an inactive precursor F0 which consists of 553 amino 
acids.  The F0 must be cleaved into two biological active disulfide-linked F1 and F2 subunits by 
host-cell protease (Lamb and Parks, 2007).   The F1 and F2 polypeptides are derived from the 
carboxyl-terminus and amino-terminus, respectively (Lamb and Parks, 2007). The sequences 
composition at the cleavage site is one of the primary determinants of virulence. For the 
velogenic and mesogenic strain of NDV, The F cleavage site consists of multiple basic amino 
acid (112(R/K)RO(R/K)RF117), while for the lentogenic strains, the sequences at the cleavage site 
are 112(G/E)(K/R)Q(G/E)RL117 without multiple basic amino acids (Kawahara et al., 1992;   
Sakaguchi et al., 1991). The F protein of virulent viruses can be cleaved by host proteases which 
are found in a wide range of cells and tissues, whereas the F protein of lentogenic viruses can be 
cleaved only by trypsin-like enzymes which are only found in the respiratory and intestinal tracts 




in severe clinic signs in nervous system and high mortality. The cleavage site of F0 protein is a 
major determinant of NDV virulence (Peeters et al., 1999; Panda et al., 2004b). 
The F protein of NDV directs fusion of the virion envelope with the plasma membrane of 
the host cell (Romer-Oberdorfer et al., 2003). Paramyxovirus infection can occur at the host cell 
membrane, and thus, the fusion is pH independent (Lamb and Parks, 2007). 
Paramyxovirus F protein consists of several domains that are involved in fusion. The 
amino terminus of F0, termed fusion peptide, is thought to insert into the target cell membrane. In 
the F1 peptide, two heptad repeats (HR1 and HR2) have identified as important to fusion. HR1 is 
located just carboxyl terminal to the fusion peptide; and the HR2 is located adjacent to the 
transmembrane domain. The HR2 domain has a leucine zipper motif which is thought to play a 
role in fusion (Buckland and Wild, 1989; Chamber et al., 1990; Hernandez et al., 1996).  NDV F 
protein has this leucine repeat motif which extends for four heptads. A single amino acid change 
in this leucine repeat motif of F protein will alter the requirement for HN protein in fusion in 
NDV (Sergel et al., 2000). The fully glycoslated F protein of NDV contains a 470-amino-acid 
extracellular domain, a transmembrane domain near C-terminal, and a 29-amino-acid 
cytoplasmic tail (Chen et al., 2001). The molecular weights of F0, F1 and F2 are 67 kD, 55 kD 
and 12 kD, respectively (Samson et al., 1988). The F protein is the major immunogenic protein 
of NDV. 
HN protein: HN protein is a type II membrane glycoprotein with N-terminus exposed to 
the cytoplasm while the C-terminus is in the lumen of the endomembrane compartment.   
 The HN protein is a multifunctional enzyme necessary for attachment, fusion, and 
maturation of NDV. First, during the attachment of virion to host cell, it serves to recognize the 




concert with the F protein. Most paramyxovirus F protein requires coexpression of the HN 
protein to promote membrane fusion during fusion process. The third function of HN protein is 
to serve as neuraminidase. It cleaves sialic acid on the cell surface and facilitates release 
(Crennell et al., 2000). Therefore, HN protein is one of the major protective antigens of NDV.   
 The biologically active HN protein is formed by cleavage of a small glycoslated fragment 
from the precursor, HN0, which contains 616 aa (Sato et al., 1987; Garten et al., 1980). The HN 
protein of most NDV strains includes 577 or 571 aa, since terminator codon of HN ORF is 
located before the HN0 stop codon (Romer-Oberdorfer et al., 2003). The length of HN ORF is 
one of the factors for the virulence of different NDV strains. For example, the shortest HN ORF 
(571) has only been found in some velogenic strains (e.g. Miyadera and Herts) to the date; 
whereas, avirulent strains (e.g. Queensland, Ulster and D26) produce a 616 aa HN0 precursor 
which requires proteolytic cleavage to become a biological active HN protein. A 577-amino-acid 
HN protein can be found in lentogenic strains (e.g. Clone-30 and B1), mesogenic strains (e.g. 
Beaudette C), or virulentic strains (e.g.Texas) (Romer-Oberdorfer et al., 1999; Gorman et al., 
1988&1992). 
The HN protein of NDV contains a 26-amino-acid cytoplasmic tail, a 22-amino-acid 
hydrophobic signal-transmembrane region, and a 522-amino-acid translocated carboxy-terminal 
domain that contains six potential N-linked glycosylation sites (residues 119,341,433,481,508 
and 538) (McGinnes et al., 1987). These N-linked glycosylated sites are important for NDV 
pathogenesis. The loss of single glycosylated site in the globular head or multiple sites from the 
stalk and globular head regions will result in attenuating virulence of NDV (Panda et al., 2004a). 
A hydrophobic region near N-terminus functions as both a signal sequence and a membrane 




(Samson et al., 1988). 
 
 
2.5.4 V and W proteins 
 
 Members of subfamily Paramyxovirinae encode multiple proteins from the P gene by 
RNA editing during mRNA transcription. P gene editing occurs by inserting one or two 
nontemplated G residues at the conserved editing site (UUUUUCCC) on the genome. Three 
mRNAs, P mRNA (unedited), V mRNA (with a +1 frame shift) and W mRNA (with a +2 frame 
shift) are produced at the ratio as 68:29:2 (Mebatsion et al., 2001&2003; Huang et al., 2003). V 
and W proteins are present in the infected cells but absent in viral particles. The N-terminal 
domains of these chimeric proteins are encoded by the P ORF upstream of the editing site and the 
C-terminal domains are encoded by alternative ORF downstream of the editing site;   therefore all 
three proteins are conserved at amino terminus but vary at their carboxyl terminus in length and 
amino acid composition.  
The sequences of V protein vary among the NDV strains. The carboxyl-terminal domain 
of V protein contains an IFN inhibitor; therefore it functions as an alpha interferon antagonist. 
Due to its ability to counteract the antiviral effects of interferon, V protein is considered as a 
virulence factor of NDV in its natural host, birds.  
 Sequences of W protein vary among the strains of NDV. In the case of Ulster strain, the 
length of W protein ORF is 181 aa; whereas, for those of D26, Beaudette C, and AV are of 141, 
221, and 228 aa, respectively (Steward et al., 1993). The function of the W protein of NDV has 
not been established, and work with other virus suggests that it may be an inhibitor of replication 





2.6 Nonconding regions 
 Besides coding regions, which encode viral proteins, some noncoding regions also 
present on the viral genome of NDV. Between each gene boundary, there are nontranscribed 
sequences termed intergenic sequences (IGSs). The lengths of IGS vary from 1 to 47 in NDV 
strains. In mesogenic strain Beaudette C, the first three 3’ end IGS are single nucleotide; 
whereas, the F-HN and HN-L IGSs are 31 and 47 nt, respectively (Chambers et al., 1986a&b&c; 
Krishnamurthy and Samal, 1998). During transcription, the viral RNA polymerase bypasses each 
IGS without synthesis and reiniates transcription at the next downstream gene start signal. 
Occasionally transcribes across IGS to generate readthrough polytranscripts (Collins, 1991).  
 The leader and trailer regions are not encoded as polypeptides, but they contain the 
promoters for viral RNA replication. Other noncoding regions on the viral genome are 
untranslated regions (UTR). Between each gene ORF and GS or GE, there are 5’ or 3’ UTR, 
respectively. The length and sequence compositions vary between each gene and among NDV 
strains. The role of IGS and UTR regions in NDV transcription, replication, and pathogenesis is 
not clear.  
 
2.7 Life cycle of NDV  
The replication strategy employed by NDV is similar to that of other nonsegmented 
negative-sense RNA viruses (Fig.2.3).  The initial step of replication is the adsorption of the virus 
to the cell surface receptor followed by fusion with the host cellular membrane. The fusion causes 




genome occurs in the cytoplasm. At the end of the replication cycle, the viral proteins are 





FIG.2.3 The life cycle of NDV. 










2.7.1 Virus adsorption and entry 
 
The initial step of virus entry requires the binding of the HN protein into the sialic acid-
containing receptor on the host cell surface. Following the attachment, the envelope of the virus 
fuses with the host cell plasma membrane. The fusion process is mediated by F protein. Upon 
fusion, disruption of matrix-nucleocaspid occurs and the viral nucleocapsid is released into the 
host cell cytoplasm. The entry of NDV into cells is believed to occur by direct fusion at the 
plasma membrane through a pH-independent mechanism. Recent study also suggests that NDV 
may infect the cells through an alternative route: caveolae-dependent endocytic pathway (Cantin 




The mRNA synthesis begins at the 3’ end of the genome of NDV (Fig.2.4). Since the 
uninfected host cell lacks the RNA dependent RNA polymerase, the viral RNA polymerase has to 
first transcribe the positive-stranded leader RNA at the 3’ end promoter. The first gene, NP, is 
transcribed at the NP gene start (GS) and is terminated at the NP gene end (GE). This results in 
release of the first capped and polyadenylated mRNA, NP mRNA. The transcription of 
paramyxovirus follows the “start-stop” mechanism until the last mRNA, L mRNA, is synthesized. 
That is, the polymerase stops at the upstream GE and reiniates synthesis of the next mRNA at the 
next GS. Some polymerase falls down at the intergenic sequences (IGS) region, which is located 
between the upstream GE and downstream GS signals. Some polymerase may bypass the IGS, 
and the readthrough transcripts are formed. This “start-stop” transcription results in the gradient 
of mRNA abundance that reduces according to the relative distance of the location of the 




the NP mRNA is produced at the most amount; whereas, the L gene, which is located the farthest 
to the 3’ end promoter, produces the least amount of L mRNA.  
For efficient transcription and replication, most paramyxoviruses follow the “Rule of Six”. 
That is, the length of genome has to be a multiple of six. The hexamer rule is most likely that NP 
subunit of the nucleocapsid is associated with exactly six nucleotides. Apart from NDV, other 
paramyxoviruses, such as Sendai virus and measles virus, also follow this “Rule of Six”; but the 
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FIG.2.4  Schematic diagram of Paramyxovirus transcription and replication. 
Transcription occurs in a sequential start-stop manner during which the polymerases transcribe 
the genome to produce mRNA. There is a polar attenuation of transcripts in which each 
downstream gene is transcribed less than its mediate upstream gene. Vertical line in the genome 
indicate gene junction; Oval shapes indicate nucleocapsid protein; Horizontal lines with slanted 
side bar lines indicate mRNA; and wavy lines indicate viral proteins. (Figure modified from 
Collins et al., 1996. Respiratory Syncytial virus, In: Foelds, B.N.Knipe, D.M.and Howley, P.M.. 













 The processes of replication and transcription of NDV are tightly regulated. The switch 
from transcription to replication is controlled by the NP protein. When free NP protein in the 
cytoplasm is limiting, the viral polymerase is preferentially engaged in mRNA synthesis, 
transcription, resulting in the increased free NP protein and other viral proteins. Once the amount 
of free NP protein is sufficient, the viral polymerase ignores the gene junction signal, such as GS 
and GE, and switches to replication. The full-length complementary copy, known as antigenome 
(+), is first synthesized to serve as the template for replication of negative sense genome RNA. 
Both the genome and antigenome are packaged into encapsidated nucleocapsid. Leader and trailer 
of the genome contain the specific signals for encapsidation (Blumberg et al., 1981a&b). 
 
2.7.4 Virus assembly and release 
 
 Recent studies suggest that the assembly and release of infectious NDV particles take 
place at the membrane lipid rafts (Laliberte et al., 2006; Dolganiuc et al., 2003). 
 The first step in viral assembly is the encapsidation of genome/antigenome RNA into 
nucleocapsid. The nucleocapsid is thought to be assembled in the cell cytoplasm. First, the free 
NP proteins are tightly associated with the genome RNA to form the ribonucleoprotein (RNP) 
core structure; secondly, the P and L proteins are loosely bound to RNP, forming transcriptase 
complex (Kingsbury et al., 1978). 
 The assembly of viral envelope takes place at the cell surface. The membrane proteins, F 
and HN proteins are synthesized on the rough endoplasmic reticulum (RER) and transport to the 
cell surface through the secretory pathway. Before transportation, the proteins undergo stepwise 




molecular cellular chaperones. Only the correctly folded proteins are transported out of the ER to 
the Golgi apparatus for further post translation modifications including carbohydrate chain 
modification of HN protein and cleavage of F0 protein at the multiple basic cleavage site to form 
functional F1 and F2 proteins (Doms et al., 1993). Finally, the mature F and HN proteins are 
transported to the cell plasma membrane through vesicles.  
 The M Proteins are thought to play the major role in taking the assembled RNP to the 
plasma membrane to form budding virions. Study on NDV virus-like particle (VLP) suggests that 
M-HN and M-NP interactions are responsible for incorporation of HN and NP proteins into VLPs 
and the F protein is incorporated indirectly due to interactions with NP and HN protein (Pantua et 
al., 2006). The assembled virions at the plasma membrane are then released by budding from host 
cell membrane. 
 
2.8 Reverse genetics 
 Reverse genetics technique is the method which allows generating the infectious virus 
from cloned cDNA of the viral genome. It is useful to manipulate the viral genome RNA at the 
cDNA level. 
Reverse genetics system for nonsegment, single-stranded, negative-sense (NSN) RNA 
viruses were not available before 1994. One of the reasons is that genome RNA itself is not 
infectious and requires the viral polymerase protein for the first round of mRNA synthesis. 
Rabies virus was the first NSN RNA virus to be rescued entirely from cloned cDNA in 1994 




and polymerase complex, NP, P and L proteins, from plasmids are transcribed by T7 RNA 
polymerase. 
 Since then, many negative-sense RNA viruses in the family Paramyxoviridae, such as 
simian virus 5 (He et al., 1997), human respiratory syncytial virus (Collins et al., 1995), Sendai 
virus (Garcin et al., 1995; Kato et al., 1996), and measles virus (Radecke et al., 1995), have been 
recovered from cloned cDNAs. 
 To date, reverse genetics systems have been established in several laboratories for NDV 
strains including: Lentogenic strains LaSota (Huang et al., 2001; Romer-Oberdorfer et al., 1999; 
Peeters et al.,1999), B1(Nakaya et al., 2001); mesogenic strain Beaudette C (Krishnamurthy et 
al., 2000) (Fig.2.5) and velogenic strain Herts/33 (de Leeuw et al., 2005). The availabilities of the 
reverse genetics system for NDV and other negative sense RNA viruses have provided a useful 
tool for basic studies of molecular biology and pathogenesis, leading to design of new generations 









FIG.2.5  Schematic diagram for the recovery of infectious NDV from cDNA. 
Cloned full length cDNA which is complementary to genomic RNA and plasmids which encode 
NP, P, and L proteins were co-transfected into HEp-2 cells. All plasmids are under the control of 
T7 RNA polymerase promoter. Simultaneously, HEp-2 cells were infected with recombinant 
vaccine MVA/T7 virus capable of expression T7 RNA polymerase. Infectious NDVs were 
















 Role of Intergenic Sequences in Newcastle Disease Virus RNA Transcription and 
Pathogenesis  
   (Previously published as: Yan Y and Samal SK.  2008. J.Virol. 82:1323-31.) 
3.2 Abstract 
 Newcastle disease virus (NDV), a member of the family Paramyxoviridae, has a non-
segmented negative-sense RNA genome consisting of six genes (3’-NP-P-M-F-HN-L-5’). The 
first three 3’ end intergenic sequences (IGSs) are single nucleotide (nt), whereas the F-HN and 
HN-L IGSs are 31 and 47 nt, respectively. To investigate the role of IGS length in NDV 
transcription and pathogenesis, we recovered viable viruses containing deletions or additions in 
the IGSs between the F and HN, and the HN and L genes. The IGS of F-HN were modified to 
contain an additional 96 nt or more, or deletion of 30 nt. Similarly, the IGS of HN-L were 
modified to contain an additional 96 nt or more, or deletion of 42 nt. The level of transcription of 
each mRNA species (NP, F, HN, and L) was examined by Northern blot analysis. Our results 
showed that NDV can tolerate an IGS length of at least 365 nt. The extended length of IGS 
down-regulated the transcription of downstream gene and suggested that 31 nt in the F-HN IGS 
and 47 nt in the HN-L IGS are required for efficient transcription of the downstream gene. The 
effect of IGS length on pathogenicity of mutant viruses was evaluated in embryonated chicken 
eggs, 1-day-old chicks and 6-week-old chickens. Our results showed that all IGS mutants were 




Interestingly, decreased IGS length also attenuated the viruses. These findings can have 
significant applications in NDV vaccine development. 
 
3.3 Introduction 
Newcastle disease virus (NDV) causes a highly-contagious respiratory, neurologic, or 
enteric disease in chickens, which leads to severe economic losses in the poultry industry 
worldwide. NDV isolates display a spectrum of virulence in chicken, ranging from an inapparent 
infection to 100% mortality. Strains of NDV are classified into three major pathotypes based on 
the severity of the disease produced in chickens. Avirulent, intermediate virulent and highly 
virulent strains are termed as lentogenic, mesogenic and velogenic strains, respectively. 
NDV is a member of genus Avulavirus in the family Paramyxoviridae. The genome of NDV 
is a nonsegmented, single-stranded and negative-sense RNA of 15,186 nucleotides (nt) (de Leeuw 
and Peeters, 1999; Krishnamurthy and Samal, 1998; Phillips et al., 1998). The genome contains at 
least six genes  which encode nucleocaspid protein (NP), phosphoprotein (P), matrix protein (M), 
fusion protein (F), hemagglutinin-neuramindase protein (HN), and large RNA-dependent RNA 
polymerase protein (L). Two additional proteins, V and W, may be produced by RNA editing 
during P gene transcription (Steward, 1993). The RNA genome is tightly encapsidated by the NP 
protein. This ribonucleoprotein (RNP) complex serves as the template for transcription and 
replication by viral RNA polymerase proteins, which are L and P proteins. The NDV genes are 
arranged on genomic RNA in the order 3’-NP-P-M-F-HN-L-5’. Flanking the genes are 3’ and 5’ 
extracistronic sequences, known as the leader and trailer, respectively. These leader and trailer 
regions are cis-acting regulatory elements involved in replication, transcription and packaging of 




transcriptional control sequences, known as the gene start (GS) and gene end (GE), respectively 
(Galinski and Wechler, 1991; Lamb and Parks, 1996). Between the gene boundaries are non-
coding intergenic sequences (IGSs), which vary in length from 1 to 47 nt. Each of the first three 
IGSs, NP-P, P-M and M-F gene junctions, has only one nucleotide, while the other two IGSs, F-
HN and HN-L gene junctions, are 31 nt and 47 nt, respectively (Chambers et al., 1986; 
Krishnamurthy and Samal,1998). The lengths of IGS are generally conserved in most NDV 
strains, and one of the exceptions is that the IGS in NP-P gene junction of strain D26 is 2 nt. 
However, the sequences of IGSs vary among NDV strains (Ishida et al., 1986). 
The transcription process for NDV is similar to other non-segmented negative-sense RNA 
viruses (Lamb and Kolakofsky, 1996). The viral RNA polymerase first transcribes the leader 
RNA at the 3’end of the genome. Synthesis of the leader sequence terminates at the boundary of 
the first gene (NP), and proceeds with the NP mRNA synthesis at the GS of the NP gene. 
Transcription terminates at the GE of the NP genes. The transcription complex probably passes 
over the NP-P IGS and begins transcription of the P gene. Therefore, IGSs are not copied into 
mRNAs. Transcription continues in this start-stop manner until the mRNA of the last gene, L, is 
synthesized. The mode of transcription leads to a gradient of mRNA abundance that is reduced 
according to the distance of the location of a particular gene from the 3’end of the genome. 
Replication occurs when the polymerase complex ignores the transcription stop signal at the 3’ 
end of each gene (Lamb and Parks, 2007). NDV RNA replication follows “the Rule of Six”; that 
is, efficient replication occurs only if the genome size is a multiple of six nucleotides (de Leeuw 
and Peeters, 1999). 
There are two different IGS groups among members of the Order Mononegavirales. One 




Morbillivirus, and Henipavirus, have IGS that are a conserved trinucleotide. For example, Sendai 
virus (SeV), human parainfluenza virus type 3 (hPIV3) and Hendra virus have conserved 
trinucleotide (GAA), with the exception of the HN-L IGS of SeV which is GGG (Skiadopoulos et 
al., 2000; Wang et al., 2000). Rhabdovirus vesicular stomatitis virus (VSV) has semi-conserved 
dinucleotide GA or CA as the IGS (Hinzman et al., 2002).  The IGS in the other virus group vary 
significantly in sequence and length. The IGS of human parainfluenza virus type 2 (hPIV-2) vary 
in length from 4 to 45 nt (14). For simian virus 5 (SV5) and respiratory syncytial virus (RSV), the 
IGS vary in length from 1-22 to 1-56 nt, respectively (Bukreyev et al., 2000; Collins et al., 1986; 
Hardy et al., 1999; Rassa and Parks, 1999). NDV belongs to the latter group.  
The role of IGS in transcription, replication and viral pathogenesis of the members of 
Mononegavirales is unclear. Studies using infectious recombinant RSV that vary in IGS length 
from 16 to160 nt showed that there was no significant difference in transcription or replication in 
vitro and in vivo (Bukreyev et al., 2000). Studies using VSV minigenome system showed that 
some nucleotide changes in the IGS resulted in higher levels of read-through transcription. This 
indicated that IGS plays a role in transcription termination in VSV (Hinzman et al., 2002).  
Studies with SV5 IGS showed that the length of IGS alone is not a determining factor in 
transcription termination/ polyadenylation (He and Lamb, 1999). The roles of NDV IGS in viral 
transcription, replication, and pathogenicity have not been studied. It is not known why the first 
three 3’end IGSs are only 1 nt long; whereas the next two IGSs are always 31 and 47 nt long. 
In this chapter, we have investigated the role of the length of IGS in NDV transcription and 
virulence. We have made several constructs which have either addition or deletion of nucleotides 
in F-HN and/or HN-L IGS.  The length of IGS changes were made based on the “Rule of Six”. 




technique (Krishnamurthy et al., 2000). The effect of IGS length on upstream and downstream 
gene transcription was quantified.  The data indicated that addition of nucleotides to the IGS 
length down-regulated the transcription of the downstream gene, but did not affect transcription 
of the upstream gene. The virulence of these recombinant viruses was examined by mean death 
time (MDT) in 9-day-old embryonated chicken eggs, by intracerebral pathogenicity index (ICPI) 
in 1-day-old chicks and by intravenous pathogenicity index (IVPI) in 6-week-old chickens. Our in 
vivo studies indicated that addition or deletion of nucleotides to IGS length decreased the 
virulence of mutant viruses. 
 
3.4 Materials and Methods 
 
3.4.1 Cells and viruses.   DF1 cells (chicken embryo fibroblast cell line) were maintained in 
Dulbecco’s minimal essential medium (DMEM) with 5% fetal bovine serum (FBS). HEp2 cells 
(human epidermoid carcinoma cell line) were maintained in Eagle’s minimal essential medium 
(MEM) with 5% FBS. A moderately pathogenic (mesogenic) NDV strain Beaudette C (BC) and 
recombinant viruses generated from BC virus were grown in 9-day-old specific-pathogen-free 
(SPF) embryonated chicken eggs. The modified vaccinia virus Ankara recombinant that expresses 
the T7 RNA polymerase (a generous gift of Dr. Bernard Moss, National Institutes of Health) was 
grown in primary chicken embryo fibroblast (CEF) cells. 
 
3.4.2 Constructions of NDV cDNAs with modified F-HN IGS and HN-L IGS.    Full-length 
antigenomic cDNA of NDV strain BC was cloned into plasmid pBR 322 and designated as pBC 




were confirmed by dideoxynucleotide sequencing. The mutant IGS include deletion of 30 nt in F-
HN IGS; deletions of 30 nt or 42 nt in HN-L IGS; additions of 96 nt, 210 nt, and 318 nt in F-HN 
and HN-L IGS, and a double deletion of 18 nt in F-HN IGS and 30 nt in HN-L IGS, as 
summarized in Table 3.1 and shown in Fig.3.1.  
TABLE 3.1 Summary of mutant viruses with modified IGS 
 
Gene junction No. of nucleotides change Virus name 
F-HN 30 nt deleted rBC-FHNΔ30 
F-HN 96 nt inserted rBC-FHN96 
F-HN 210 nt inserted rBC-FHN210 
F-HN 318 nt inserted rBC-FHN318 
HN-L 30 nt deleted rBC-HNLΔ30 
HN-L 42 nt deleted rBC-HNLΔ42 
HN-L 96 nt inserted rBC-HNL96 
HN-L 210 nt inserted rBC-HNL210 
HN-L 318 nt inserted rBC-HNL318 
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F gene HN geneF-HN IGS (31nt)
Mlu I
rBC-FHN96        90 nt from AMPV SH-G IGS and 6 nt of MluI
rBC-FHN210      204 nt from AMPV N gene 88 to 291 nt and 6 nt of Mlu I




HN gene                         HN-L IGS (47 nt)                            L gene
Age I
rBC-HNL96          90 nt from AMPV SH-G IGS and 6 nt of Age I
rBC-HNL210        204 nt from AMPV N gene 88 to 291 nt and 6 nt of Age I
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FIG.3.1 Structure of modified IGS between F and HN, HN and L genes of mutant NDVs. 
(A) Structure of NDV genome order. Between each gene, IGS was indicated as thin line, and 
length of each IGS is shown under the line. (B) Structures of IGS between the F and HN genes of 




of IGS between the HN and L genes of rBC-HNL96, 210, and 318. The 47 nt represents the 
length of wild type HN-L IGS. (D) Structure of IGS between the F and HN, and HN and L genes 
of rBC-FHNΔ18HNLΔ30. The 18 nt and 30 nt were deleted from F-HN and HN-L IGS, 
respectively. (E)  Structure of IGS between the F and HN genes of rBC-FHNΔ30. The 30 nt were 
deleted from F-HN IGS. (F) Structures of IGS between the HN and L genes of rBC-HNLΔ30. 
The 30 nt were deleted from HN-L IGS. (G) Structure of rBC-HNLΔ42. The 42 nt were deleted 




















For F-HN IGS insertion, different lengths (90 nt, 204 nt or 312 nt) of avian 
metapneumovirus (AMPV, GenBank accession No. AY590688) sequences were amplified by 
PCR with Mlu I site at both ends. The amplified sequences were digested with Mlu I and inserted 
into the full-length cDNA clone pBC, which contains a unique Mlu I site in IGS between F and 
HN genes. AMPV sequences were chosen because it is a closely related avian paramyxovirus. 
The amplified AMPV sequences were: 90 nt sequences were from AMPV SH-G IGS; 204 nt 
sequences were from AMPV N gene 88 to 291 nt; and 312 nt sequences were from AMPV N 
gene 88 to 400 nt. 
For deletion of nucleotides in the F-HN IGS, three rounds of PCR were performed. In the 
first round PCR, template pBC was amplified by primers Not I (+) (5’- CAA ATA ACA GCG 
GCC GCA GCT C -3’) and HN6340 (-) (5’- CTC TTA CCG TTC TAC CCG TGT TTT TTC 
TAA ACT CTC CGA -3’). This PCR product contained 30 nt deletion in the F-HN IGS and a 
Not I site, which is present in the upstream gene F. In the second round PCR, template pBC was 
amplified by primers HN6272 (+) (5’-TCG GAG AGT TTA GAA AAA ACA CGG GTA GAA 
CGG TAA GAG -3’) and HN/L (-) (5’- AAG GCC TTG TCT GCT GAG AAT GAG GTG -3’). 
This PCR product contained Age I site, which is present in the HN-L IGS and 30 nt deletion in 
the F-HN IGS.  In the third round PCR reaction, the first and second PCR products were used as 
templates, and primers, Not I (+) and HN/L (-), were used to amplify the templates. This PCR 
product was digested with Not I and Age I and then cloned into pBC, and designated as pBC-
FHNΔ30.   
        For HN-L IGS insertion, different length (90 nt, 204 nt or 312 nt) sequences were 
amplified with Age I site on the both ends by PCR. These HN-L IGS insertion sequences were 




and then inserted into full-length cDNA clone pBC, which contained a unique Age I site in IGS 
between HN and L genes. 
For HN-L IGS deletion, pBC-HNLΔ30, primers F6202 (+) (5’- GTG AAC ACA GAT GAG 
GAA CG - 3’) and HNL8366 (-) (5’-TTT ACC GGT TAC ATT TTT TCT TAA TCG AGG GAC 
TAT TGA C-3’) were used to amplify the template pBC. The PCR product was digested with 
Mlu I and Xba I and then cloned into pBC.  For pBC-HNLΔ42, three rounds of PCR were 
performed. In the first round PCR, primers HN7513 (+) (5’- CGC ATA CAG 
CAGGCTATCTTA -3’) and HNL 8390 (-) (5’- GAG CTC GCC ATG TCC TAC CCG TAC 
ACA TTT TTT CTT AAT CGA GGG ACT ATT GAC - 3’) were used to amplify the template 
pBC. This PCR product contained Spe I site, which is present in the HN gene and a 42 nt deletion 
in the HN-L IGS. In the second round PCR, primers HNL8300(+) (5’- GTC AAT AGT CCC 
TCG ATT AAG AAA AAT GTG TAC GGG TAG GAC ATG GCG AGC TC -3’) and XbaI (-) 
(5’- AGT ACT CCG GTT ATT CTA GAA TTG TGG TTG - 3’) were used to amplify template 
pBC. This PCR product contained Xba I site and a 42 nt deletion in the HN-L IGS.  In the third 
round PCR, primers HN7513 (+) and XbaI were used to amplify templates from the first and 
second round PCR reactions. The PCR product was digested with SpeI and XbaI and then cloned 
into pBC.  
For the double deletion construct which contained deletions of 18 nt in F-HN IGS and 30 nt 
in HN-L IGS ( pBC-FHNΔ18HNLΔ30 ), primers HN6290(+) (5’- ACT ACG CGT GAT ATA 
CGG GTA GAA CGG TAA GAG AGG CCG - 3’) and HN8366(-) (5’- TTT ACC GGT TAC 
ATT TTT TCT TAA TCG AGG GAC TAT TGA C - 3’) were used to amplify pBC, and the 
product contained deletions of 18 nt in F-HN IGS and 30 nt in HN-L IGS. The PCR product was 




All manipulated regions in the NDV cDNAs were sequenced to confirm the presence of 
desired mutations. 
 
3.4.3 Recovery of recombinant NDV.   Recombinant NDVs were recovered by co-transfection 
of each NDV cDNA mutant plasmid with support plasmids encoding NP, P and L proteins into 
HEp-2 cells. Simultaneously, HEp-2 cells were infected with recombinant vaccinia virus 
(MVA/T7), which is capable of synthesizing T7 RNA polymerase. Three or four days after 
transfection, the cell culture supernatant was used to recover the recombinant NDV by either 
passaging in  DF-1 cells until a virus-specific cytopathic effect (CPE) appeared or injecting into 
the allantoic cavities of 9-day -old embryonated chicken eggs until the allantoic fluid showed HA 
positive (Krishnamurthy et al., 2000). 
 
3.4.4 Reverse transcription PCR (RT-PCR) and sequence analysis of modified IGS.      Total 
RNAs were isolated from the mutant NDVs infected allantoic fluid in the 9-day-old SPF chicken 
embryos using RNeasy Mini Kit (Qiagen) according to manufacturer’s recommendations. 
Reverse transcription was performed using SuperScript II reverse transcriptase (Invitrogen). The 
positive-sense primers used for RT reaction were F6202 (+) for F-HN IGS mutants; and HN/L (+) 
(5’-TCC GCG ACA CCA AGA ATC AAA C-3’) for HN-L IGS mutants.  For F-HN IGS 
mutants, the generated cDNA products were PCR amplified using primers, F 6202 (+) and HN 
6414(-) (5’-CAT GAC TGA GGA CTG CTG-3’).  For HN-L IGS mutants, the primers, HN/L (+) 
and HN/L (-), were used for the PCR amplification.  The RT-PCR products spanning the F-HN 






3.4.5 Characterization of recombinant NDVs.   The growth kinetics of recombinant mutant 
viruses was evaluated by multiple-step growth assay. DF1 cells in duplicate wells of six-well 
plates were infected with viruses at a multiplicity of infection (M.O.I.) of 0.01 plaque forming 
unit (PFU).After one hour adsorption, the cells were washed with DMEM and then covered with  
DMEM containing 5% FBS at 37oC in 5% CO2. Supernatant was collected and replaced with an 
equal volume of fresh medium at 8 h intervals until 64 h post infection. The titer of virus in the 
sample was quantified by plaque assay in DF1 cells. All plaque assays were performed in six-well 
plates. Briefly, monolayers of DF1 cells were infected with 0.2 ml of 10-fold diluted fresh virus. 
After 1 h adsorption, cells were covered with DMEM containing 2% FBS, 1% methylcellulose, 
and incubated at 37oC in 5% CO2. Four days later, the cells were fixed with methanol and stained 
with crystal violet. The average plaque diameter was calculated by measurement of ten plaques 
for each virus. 
 
3.4.6 Northern blot hybridization.      The total intracellular RNAs were isolated from virus-
infected DF1 cells using RNeasy mini Kit (Qiagen). The RNAs were electrophoresed in 
denaturing 1.5% agarose gels containing 0.5 M  formaldehyde, transferred onto a nitrocellulose 
membrane, and then hybridized with a P32 labeled double-stranded cDNA probe specific to NDV 
NP, F, HN or L gene. The bands corresponding to the individual NDV mRNAs were quantified 
by Fuji phosphor imager.  
3.4.7 Pathogenicity Studies.   The pathogenicity of the mutant viruses was determined by three 




time (MDT) test in 9-day-old embryonated chicken eggs, intracerebral pathogenicity index (ICPI) 
test in 1-day-old chicks and intravenous pathogenicity index (IVPI) test in 6-week-old chickens. 
Briefly, for MDT, a series of 10-fold (10-6-10-9) dilutions of fresh infective allantoic fluid 
were made in sterile PBS, and 0.1 ml of each diluent was inoculated into the allantoic cavities of 
five 9-day-old SPF embryonated chicken eggs (BEE eggs company, PA) and incubated at 37oC. 
Each egg was examined 3 times daily for 7 days, and times of any embryo death were recorded. 
The minimum lethal dose is the highest virus dilution that causes all the embryos inoculated with 
the dilution to die. The MDT is the mean time in hours for the minimum lethal dose to kill all the 
inoculated embryos. The MDT has been used to classify NDV strains into the following groups: 
velogenic strains (taking less than 60 h to kill); mesogenic strains (taking 60 -90 h to kill); and 
lentogenic strains (taking more than 90 h to kill). 
  For ICPI, 0.05 ml (1:10 dilution) of fresh infective allantoic fluid of each virus was 
inoculated into groups of ten 1-day-old SPF chicks via the intracerebral route. The inoculation 
was done using a 27-gauge needle attached to a 1 ml stepper syringe dispenser that was set to 
dispense 0.05 ml of solution per inoculation. The birds were inoculated by inserting the needle up 
to the hub into the right or left rear quadrant of the cranium. The birds were observed for clinical 
symptoms and mortality once every 8 h for a period of 8 days. At each observation, the birds 
were scored: 0 if normal, 1 if sick and 2 if dead. ICPI is the mean score per bird per observation 
over the 8-day period. Highly virulent (velogenic) viruses give values approaching 2, and 
avirulent (lentogenic) viruses give values close to 0.   
For IVPI, 0.1 ml 1:10 dilution of fresh infective allantoic fluid of each virus was inoculated 
intravenously into groups of ten 6-week-old SPF chickens. The birds were observed for clinical 




were scored: 0 if normal, 1 if sick, 2 if paralyzed and 3 if dead. IVPI is the mean score per bird 
per observation over 10-day period. Highly virulent (velogenic) viruses give values approaching 3 
and avirulent (lentogenic) viruses give values close to 0.  
Each experiment had mock-inoculated controls that received a similar volume of sterile PBS 
by the respective routes. The MDT, ICPI and IVPI values were calculated as described by 




3.5.1 Construction of rNDVs with F-HN and HN-L IGS of different lengths.   We 
manipulated the length of IGS between F and HN genes and HN and L genes, in a full-length 
NDV strain Beaudette C antigenomic cDNA clone, pBC. The reason for selecting the F-HN and 
HN-L IGS is that these two IGSs include 31 nt and 47 nt, respectively, but the other three IGSs 
(NP-P, P-M, and M-F) have only one nucleotide. We wanted to know why the IGS of F-HN and 
HN-L are longer than other IGSs of NDV, and what effect the IGS length has on expression 
level of mRNA transcription, virus replication and pathogenicity of the virus. We made a 30 nt 
deletion in F-HN IGS, 30 nt and 42 nt deletions in HN-L IGS, and a double deletion that 
included 18 nt deletion in F-HN IGS and 30 nt deletion in HN-L IGS. We also made 6 additional 
constructs in which 96 nt, 210 nt and 318 nt were added to F-HN and HN-L IGS. The numbers 
of deletion or addition nucleotides were adjusted so that the entire genome length of NDV 
obeyed the “Rule of Six” (Phillips et al., 1998). The schematic and details of the constructs are 




The recombinant viruses were recovered by reverse genetics technique as described 
previously (Krishnamurthy et al., 2000).  The sequences of modified IGS were confirmed by RT-
PCR and sequencing. There was no noticeable difference in the recovery of recombinant viruses 
from different constructs.  
 
3.5.2 The modified IGSs are stable in rNDVs.   Mutant viruses were passed five times in 9-day-
old embryonated chicken eggs to examine the stability of the modified IGS length. Allantoic fluid 
from each passage was collected and analyzed by RT-PCR using primers that flanked the F-HN 
and HN-L IGS. The lengths of PCR product from rNDV modified F-HN and HN-L IGS are 
shown on the agarose gel (Fig.3.2). The integrity of the RT-PCR product was confirmed by 
sequence analysis. Our results did not show any change in length and sequence of rNDVs IGS 
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FIG.3.2 RT-PCR analysis of the F-HN and HN-L IGS from mutant NDVs. 
Total RNAs isolated from allantoic fluid after the fifth passage of mutant NDVs in the 9-day-old 
SPF chicken embryos were analyzed by RT-PCR using primers spanning F-HN and HN-L IGS. 
The RT-PCR products were separated on 1% agarose gel.  (A) RT-PCR of recombinant viruses 
for F-HN IGS. Lanes 1: 1kb DNA ladder;  2: rBC;  3: rBC-FHNΔ18HNLΔ30;  4: rBC-FHNΔ30;  
5: rBC-FHN96;  6: rBC-FHN210;   and 7: rBC-FHN318. (B) RT-PCR of recombinant viruses for 
HN-L IGS.  Lanes 1: 1 kb DNA ladder;  2: rBC;  3: rBC-FHNΔ18HNLΔ30;  4: rBC-HNLΔ30;  5: 












3.5.3 Increased IGS length affects viral replication in vitro and results in reduced plaque 
size.  Multi-step growth kinetics was performed in order to analyze the replication of rNDV in 
vitro. DF-1 cell monolayers were infected at an MOI of 0.01 PFU per cell, and supernatant 
samples were taken at 8 h intervals till 64 h post infection.  Samples were then quantified by 
plaque assay. There was no significant difference in growth kinetics between the various mutant 
viruses and the parental virus rBC, with the exception that rBC-HNL318 showed slightly delayed 









































FIG.3.3  Kinetics of replication of mutant NDVs in DF-1 cells. 
DF-1 cell monolayers were infected in duplicate with the indicated viruses at an M.O.I. of 0.01 
PFU per cell for 1 h. The cells were washed with DMEM and then covered with DMEM 
containing 5% FBS at 370C in 5% of CO2. Aliquots of the supernatant medium were taken at 8 h 
intervals till 64 h post infection, replaced with an equal volume of fresh medium, flash-frozen, 









The plaques formed by the various rNDVs in the DF-1 cell monolayer were visualized by 
staining with crystal violet (Fig.3.4). The plaque size was measured in several independent 
experiments. Viruses that had deletions either in F-HN or HN-L IGS were indistinguishable from 
rBC on the basis of plaque size. Interestingly, the double deletion virus, rBC-FHNΔ18HNLΔ30, 
produced slightly larger size of plaques than those of the parental rBC. The viruses, with the 
addition of 96 nt or more in either F-HN or HN-L IGS, produced progressively smaller size of 
plaques compared to those of rBC. The average sizes of ten plaques of various rNDVs in a typical 
experiment were as follows: rBC ,1.48 mm, (standard deviation, SD, 0.19); rBC-
FHNΔ18HNLΔ30, 1.54 mm (SD 0.16); rBC-FHNΔ30, 1.44 mm (SD 0.24); rBC-FHN96, 1.25 
mm (SD 0.24); rBC-FHN210, 0.96 mm (SD 0.19); rBC-FHN318, 0.68 mm (SD 0.21); rBC-
HNLΔ30, 1.41 mm (SD 0.23); rBC-HNLΔ42, 1.40 mm (SD 0.24); rBC-HNL96, 1.19 mm (SD 







FIG.3.4 Plaque morphology of mutant NDVs containing increased or decreased length of IGS in 
F-HN and HN-L gene junctions. 
Recovered viruses were titrated in duplicate in 6-well plates. Supernatant collected from virus-
inoculated samples was serially diluted, and 0.2 ml of each diluent was added into confluent DF1 
cells per well. After 1 h of adsorption, cells were overlaid with DMEM containing 2% FBS and 
1% methylcellulose, and incubated at 370C for 4 days. The cells were then fixed with methanol 















3.5.4 Transcription of the downstream gene is down-regulated by increased IGS.      
Transcription of the upstream or downstream gene of the recombinant viruses was analyzed by 
Northern blot hybridization. DF-1 cells were infected with viruses at an MOI of 5 PFU per cell 
and harvested at 24h post infection. The total intracellular RNA was isolated and analyzed by 
Northern blot hybridization with a double-stranded radiolabeled cDNA probe specific to NP, F, 
HN or L gene. The results are shown in Fig.5 and accumulation of transcripts of the downstream 
and upstream genes was quantified by Fuji Phosphor Imager. F-HN IGS mutants, rBC-FHN210 
and rBC-FHN318, showed decreased transcription of the downstream gene, HN (panel A, lanes 
5and 6); but no significant change in the transcription level of the upstream gene, F (panel C, lane 
5 and 6). Similarly, HN-L IGS mutants, rBC-HNL210 and rBC-HNL318, showed decreased 
transcription of the downstream gene, L (panel B, lanes 10 and 11); but no significant change in 
the transcription level of the upstream gene, HN (panel A, lanes 10 and 11).  These results 
indicated that extending IGS length probably affected initiation of downstream gene transcription, 
but probably had no effect on the transcription of the immediate upstream gene. In addition, there 
was no difference in the level of NP gene expression between the viruses, indicating that 
increasing IGS length has no effect on upstream gene transcription. Our studies also indicated that 
increased the length of F-HN IGS decreased the level of F-HN dicistronic read-through mRNA 
production. However, we were unable to clearly quantify HN-L dicistronic mRNA level in the gel 
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FIG.3.5 Northern blot analysis of RNAs synthesized by mutant NDVs bearing modified F-HN 
and HN-L IGS. 
(A-D) DF-1 cells were infected with the indicated virus (M.O.I. of 5 PFU), incubated for 24 h, 
and harvested; and then total intracellular RNA was extracted. The RNA was separated by 
electrophoresis in formaldehyde agarose gel, transferred onto a nitrocellulose membrane, and 
hybridized with a P32 labeled double-stranded cDNA probe specific to the HN, L, F, or NP gene, 
as indicated. Positions of the specific gene, read-through mRNA, genomic, and antigenomic 
RNAs are indicated.  Lanes: 1, rBC ; 2, rBC- FHNΔ18HNLΔ30; 3, rBC- FHNΔ30;  4, rBC-
FHN96;  5, rBC-FHN210; 6, rBC- FHN318 ; 7, rBC-HNLΔ30;  8, rBC- HNLΔ42;  9, rBC- 








3.5.5 Pathogenicity studies of rNDVs containing decreased or increased F-HN and HN-L 
IGS lengths.       We wanted to determine the effect of increased or decreased IGS length on 
pathogenicity of the recombinant viruses. At present, a definitive assessment of NDV virulence is 
based on the following in vivo tests: MDT in embryonated SPF chicken eggs, ICPI test in 1-day-
old chicks, and IVPI test in 6-week-old chickens. We examined the virulence of parental rNDV 





















TABLE 3.2.  Pathogenicity of mutant viruses in chicken embryos, chicks and chickens 
Virus MDT (h)a ICPIb IVPIc 
rBC 60 1.49 2.06 
rBC-FHN∆18HNL∆30 60 1.28 0.72 
rBC-FHN∆30 58 1.36 1.04 
rBC-FHN96 59 1.44 0.34 
rBC-FHN210 60 1.31 0.20 
rBC-FHN318 60 1.06 0.14 
rBC-HNL∆30 64 1.45 0.99 
rBC-HNL∆42 59 1.44 0.44 
rBC-HNL96 58 1.11 0.54 
rBC-HNL210 60 0.61 0.00 
rBC-HNL318 68 0.47 0.00 
 
a Mean death time in 9-day-old embryonated chicken eggs (h) 
    (>90: lentogen; 60-90: mesogen; <60: velogen; Alexander, 1989). 
bIntracerebral pathogenicity index in 1-day-old chicks  
    (0.0-0.5: lentogen; 1.0-1.5: mesogen; 1.5-2.0: velogen; Alexander, 1989).  
cIntravenous pathogenicity index in 6-week-old chickens  







The MDT test results showed that the parental rBC took 60 h to cause embryo mortality. 
All recombinant viruses showed MDT similar to that of rBC, except rBC-HNLΔ30 and rBC-
HNL318, which took 4 h and 8 h longer, respectively, in causing the death of embryos (Table 
3.2).  
The ICPI value of parental rBC was 1.49 (out of a maximum 2.00) (Table 3.2). The ICPI 
values of rNDVs containing decreased IGS length (rBC-FHNΔ30, rBC-HNLΔ30, and rBC-
HNLΔ42) were similar to that of the parental rBC. However, the ICPI value of rBC-
FHNΔ18HNLΔ30 was 1.28, which was lower than that of the parental rBC. Interestingly, the 
ICPI values of recombinant viruses decreased as the length of the IGS increased. In the case of 
increased F-HN IGS length, the ICPI values for rBC-FHN96, rBC-FHN210, and rBC-FHN318 
were 1.44, 1.31, and 1.06, respectively. In the case of increased HN-L IGS length, the ICPI values 
of rBC-HNL96, rBC-HNL210, and rBC-HNL318 were 1.11, 0.61 and 0.47, respectively. These 
results indicated that increased HN-L IGS length reduces the pathogenicity of rNDV more than 
that of viruses with the increased F-HN IGS length. To determine the amount of each 
recombinant virus required to cause the death of 1-day-old chicks by intracerebral route, the brain 
tissues from the dead chicks were plaque assayed in DF-1 cells. Our results showed that all 
recombinant NDVs grew to similar titer (104-105 PFU/gm brain tissue) in the brain at the time of 
chick death, but the time to cause the death was longer in viruses with increased IGS length. The 
viruses recovered from the brain tissues of dead chicks were sequenced to determine the stability 
of the modified IGS. Our results showed that the modified IGSs in rNDVs were stable after their 
growth in the chick brain. 
The results obtained by IVPI tests in 6-week-old chickens for the mutant viruses were 




of 3.00), but the IVPI values of all mutant viruses were much lower (ranging from 0.00 to 1.04), 
indicating that both decreased and increased IGS length reduced the virulence of rNDVs. All 
rNDVs containing decreased IGS length showed reduced virulence. The IVPI values for rBC-
FHNΔ18HNLΔ30, rBC-FHNΔ30, rBC-HNLΔ30, and rBC-HNLΔ42 were 0.72, 1.04, 0.99, and 
0.44, respectively. Again interestingly, the IVPI values of rNDVs decreased as the length of the 
IGS increased. In the case of increased F-HN IGS length mutants, the IVPI values for rBC-
FHN96, rBC-FHN210 and rBC-FHN318 were 0.34, 0.20 and 0.14, respectively. In the case of 
increased HN-L IGS length mutants, the IVPI values for rBC-HNL96, rBC-HNL210 and rBC-
HNL318 were 0.54, 0.00 and 0.00, respectively. These results confirmed that increased HN-L 
IGS length reduced the pathogenicity of rNDVs in adult chickens more than that of the viruses 
with increased F-HN IGS length. Furthermore, our results showed that the IVPI test is more 
sensitive than the ICPI test in determining the pathogenicity of NDV strains. MDT test is the least 
sensitive test to assess pathogenicity of NDV.  
 
3.6 Discussion 
The length and sequence of IGSs vary among the member of Mononegavirales. In some 
viruses, such as VSV, Sendai virus and measles virus, the IGSs are conserved dinucleotide or a 
trinucleotide, whereas in some other viruses, such as NDV, RSV and SV5, the IGS vary in length 
and in sequence composition. Previous studies have indicated that in virus with conserved IGS 
sequences, the IGS plays an important role in termination of upstream mRNA transcription and 
initiation of downstream mRNA synthesis (Barr et al., 1997; Stillman and Whitt, 1998; Tordo et 
al., 1986). On the contrary, in some other virus, such as RSV, IGS has little effect on either 




the first three 3’-proximal IGSs are single nucleotide, whereas, the last two 5’-proximal F-HN 
and HN-L IGSs are non-conserved 31 and 47 nt, respectively. In this study, we analyzed the 
effect of decreasing or increasing length of F-HN or HN-L IGS on mRNA transcription and on 
the eventual pathogenicity of the virus in its natural host, chicken. 
 Increasing either the F-HN or HN-L IGS had no significant effect during multi-step 
growth kinetics of the mutant NDVs in cell culture except rBC-HNL318 virus showed decreased 
growth kinetics. However, the sizes of plaque varied among the mutant viruses. Based on plaque 
size, the level of attenuation of in vitro growth increased as length of IGS increased. Our 
research confirmed previous observation with the RSV IGS study that plaque size was 
remarkably sensitive to small changes in IGS length (Bukreyev et al., 2000). It is unknown 
whether the effect of increased in vitro attenuation was due to the effect of increased genome 
length of the recombinant NDV or due to alteration of mRNA transcription level resulting from 
the increased IGS length.  
 Decreasing either the F-HN or HN-L IGS had no discernible effect during multi-step 
growth kinetics of mutant NDVs in cell culture. However, when the plaque size of IGS deletion 
viruses were compared, we found that the plaque sizes of single IGS deletion viruses were 
similar or slightly smaller than that of the parental virus. This result indicated that the decreased 
plaque size observed with viruses of increased or decreased IGS length were probably not due to 
the effect of simple increase in genome length but could be due to the alteration of mRNA 
transcription level. Surprisingly, the plaque size of the double IGS deletion virus rBC-
FHN∆18HNL∆30 was increased. Although it is unclear why the plaque size was increased, it is 
possible that the augmentation effect was due to ratio of mRNAs produced as a result of double 




 In the present study, we demonstrated that NDV can tolerate an IGS length of at least 365 
nt. The IGS length was stable after five passages in chicken and chicken embryos. Among the 
members of Mononegavirales, the IGSs of Ebola virus vary from 3 to 143 nt (Sanchez et al., 
1993), Rabies virus has a 423 nt long G-L intergenic region which is thought to be a pseudogene 
(Tordo et al., 1986), and human metapneumovirus IGSs vary from 2 to 126 nt (Ishiguro et al., 
2004). Recombinant RSV was shown to tolerate an IGS length of 160 nt (Bukreyev, 2000). 
Therefore, to our knowledge this is one of the largest IGS in Mononagavirales. 
 During virus recovery studies, we came across an interesting observation.  When the F-
HN IGS was replaced with random non-viral sequences we were unable to recover viable NDV 
even after five attempts. In all those attempts the parental virus and the viruses, in which F-HN 
or HN-L IGS were replaced with avian metapneumovirus sequences, were recovered. Although 
these experiments need to be repeated with additional viral and non-viral random sequences, our 
research indicated that certain non-viral sequences can not be used to replace NDV IGS. It is 
possible that the NDV polymerase recognizes sequences from a distantly related virus but fails to 
recognize randomly generated non-viral sequences. 
 Our observations of diminution of plaque size with either increased or decreased IGS 
length indicated that it was probably not due to the result of change in genome length but 
associated with a change in the efficiency of sequential transcription. As expected, our Northern 
blot analysis showed that increased F-HN or HN-L IGS length resulted in decreased transcription 
of the downstream gene. We were unable to detect any significant effect on the transcription of 
the upstream gene. Our results were consistent with the study of hPIV3 (Skiadopoulos et al., 
2000). hPIV3 has a conserved trinucleotide GAA or GCG as IGS. Studies showed that insertion 




downstream gene (Skiadopoulos et al., 2000). On the contrary, for RSV in which IGSs vary in 
length and in sequence composition, studies with minigenome and infectious recombinant virus 
showed that RSV IGS did not modulate transcription (Bukreyev et al., 2000; Kuo et al., 1996). 
 The pathogenicity studies showed that all IGS mutants were attenuated by ICPI and IVPI 
tests. The results showed that the level of attenuation increased as the length of IGS increased. 
For example, rBC HNL210 and rBC-HNL318 were completely attenuated by the IVPI test. 
These results are in agreement with the studies of RSV, where increasing IGS length affected 
viral pathogenicity in mice (Kuo et al., 1996). Interestingly, our results showed that decreasing 
the length of IGS also affected viral pathogenicity. These findings suggested that either 
increasing or decreasing the length of IGS alters the level of downstream gene transcription, 
which changes the ratios of viral transcripts, and probably these ratios are very important for 
virus growth and pathogenicity. It is possible that the most effective ratios of transcripts in NDV 
are obtained by having 1 nt in the first three 3’ end IGS and 31 and 47nt in the last two IGS. 
Therefore, NDV has maintained these IGS lengths over the years without any changes. We also 
observed that the HN-L IGS was more amenable to attenuation than the F-HN IGS. This result 
indicated that the level of L protein is probably more important for virus growth and any minor 
change in its level can have a dramatic effect on virus growth and pathogenicity. 
 Previously, it has been suggested that the ability of NDV strains to produce large size 
plaques is related to virulence for chicken (Reeve and Poste, 1971). Seemingly, our data differ 
from this suggestion in that the double IGS deletion virus rBC-FHN∆18HNL∆30 produced a 
slightly larger size plaque compared to that of the parental rBC virus, despite its attenuation in 




 Our pathogenicity studies showed that the IVPI test was more sensitive than the ICPI test 
which was in turn more sensitive than the MDT test to assess the pathogenicity of NDV IGS 
mutants. These results indicated that the immune system of the host also plays an important role 
in the pathogenicity of NDV. The virus has to overcome a mature immune system in a 6-week-
old chicken in the IVPI test than a less developed immune system in a 1-day-old chick in the 
ICPI test or in a 9-day-old embryo in the MDT test. Therefore, any minor difference in the 
pathogenicity of a NDV mutant could be amplified in the IVPI test than in the ICPI or the MDT 
test. 
 The results presented in this paper can have significant applications in the development 
of live attenuated NDV vaccines. One of the major problems encountered in the current live 
attenuated NDV vaccines is the undesirable pathogenicity of the vaccine virus. Since field strains 
of low virulence are currently used as NDV vaccines, the pathogenicity of these strains can not 
be changed. There is a great need to develop a live NDV vaccine that is immunogenic but less 
pathogenic. Our research showed a new method to attenuate NDV strains. We hope that by 
changing the length of IGS the pathogenicity of an NDV strain can be adjusted to the desired 
level without affecting the immunogenicity of the vaccine virus, which will greatly benefit the 










 The untranslated regions of the Newcastle disease virus hemagglutinin neuraminidase 
gene play essential roles in virus replication and pathogenesis 
 
4.2 Abstract 
Newcastle disease virus (NDV) has a non-segmented negative-sense RNA genome 
consisting of six genes. Each gene is flanked by a conserved transcriptional control sequence, 
gene start (GS) and gene end (GE). Between the GS and open reading frame (ORF) and between 
the ORF and GE, there are untranslated regions (UTRs). To investigate the role of the UTRs of 
Hemagglutinin Neuraminidase (HN) gene in replication and pathogenesis, several NDVs with 
deletions in the 5’ and 3’ UTRs of HN gene were generated. The levels of HN mRNA 
transcription, HN protein expression in infected cells, and HN protein incorporation into viral 
particles were examined. Pathogenicity of the recombinant NDVs was evaluated in chickens. 
Our results showed that the UTRs of HN did not noticeably affect in vitro replication of 
recombinant viruses. Complete deletions of 5’ or 3’ UTRs of HN gene decreased accumulations 
of HN mRNA in infected cells; whereas, complete deletions of HN 5’ UTR affected translation 
of HN protein and incorporation of HN protein into virus particles. In addition, complete deletion 
of 5’ UTR of HN mRNA attenuated the pathogenicity of NDV mutants in 1-day-old chicks and 
2-week-old chickens. These results suggest that the UTRs of NDV genes may not be absolutely 




Replacement of the HN 5’ and 3’UTRs with the corresponding UTRs of NP gene showed that 
the functions of HN UTRs could be fulfilled by the NP UTRs, indicating that the requirement of 
UTR sequence is nonstringent.  
 
4.3 Introduction 
Newcastle disease virus (NDV) causes a highly-contagious respiratory and neurological 
disease in chickens (Taylor, 1964). The disease is prevalent worldwide and causes the great 
economic loss to poultry farmers. All known strains of the virus are of a single serotype, but they 
differ widely in virulence. Strains of NDV are classified into three pathotypes depending on the 
severity of disease produced in chickens. Lentogenic strains do not cause disease and are termed, 
“avirulent”, viruses of intermediate virulence are termed, “mesogenic”, while virulent strains that 
cause high mortality are termed, “velogenic” (Alexander, 1989). 
NDV is a member of the genus Avulavirus in the family Paramyxoviridae. The genome of 
NDV is a nonsegmented, single-stranded, negative-sense RNA of 15,186 nucleotides (nt) 
(Krishnamurthy et al., 2000). The genome contains six genes (3’-NP-P-M-F-HN-L -5’), which 
encode six structural proteins: nucleoprotein (NP), phosphate protein (P), matrix protein (M), 
fusion protein (F), hemagglutinin-neuraminidase protein (HN), and large polymerase protein (L) 
(de Leeuw and Peeters, 1999). Two additional proteins, V and W, are produced from the P gene 
by RNA editing (Steward et al., 1993). Like other paramyxoviruses, the entire length of the 
genome and antigenome of NDV are always tightly bound by the NP protein (Lamb and Parks, 
2007). The genome of NDV is flanked by 3’ leader and 5’trailer regions, which are cis-acting 
regulatory elements involved in transcription, replication, and packaging of the genomic and 




vary in length and sequence among genes. The IGS are not copied into mRNAs. Each gene is 
flanked by conserved transcriptional initiation and termination control sequences, known as gene 
start (GS) and gene end (GE) signals, respectively (Lamb and Parks, 2007). 
 The mechanism of transcription and replication of NDV is similar to those of other 
paramyxoviruses (Lamb and Parks, 2007). Transcription begins at a single promoter at the 3’ 
leader end and the genes are copied in a sequential manner into individual mRNAs by a start-
stop mechanism guided by GS and GE signals. Genome replication occurs by synthesis of 
complementary positive-sense copies of the genome called antigenomes, which serve as 
templates for synthesis of progeny genomes. 
 In paramyxoviruses, mRNAs generally contain open reading frames (ORFs) which are 
flanked by 5’ and 3’ untranslated regions (UTRs). These UTRs are neither conserved in 
sequence nor in length among different mRNAs. Very little is known about the functions of these 
UTRs in transcription, translation and pathogenesis. In Measles virus (MeV), the M and F 
mRNAs have unusually long 3’ and 5’ UTRs, respectively (Barrett et al., 1991). These long 
UTRs occupy as much as 6.4% of the virus genome. It has been known that these long UTRs in 
MeV are not essential for viral replication, but they play an important role in replication and 
pathogenicity of the virus. The long 3’UTR of M mRNA increases its translation, promoting 
virus replication, whereas, the long 5’ UTR of F mRNA inhibits the F protein production thus 
inhibiting virus replication and greatly reducing cytopathogenicity (Cathomen et al., 1995; 
Takeda et al., 2005). However, the functions of normal paramyxovirus 5’ and 3’ UTRs in the 
context of virus replication and pathogenicity remain unknown. 
 In this study, we have analyzed the roles of 5’ and 3’ UTRs of the HN mRNA of NDV in 




involved in important biological functions in the virus life cycle, but also in inducing a high level 
of NDV-specific neutralizing antibody in chickens. In NDV mesogenic strain Beaudette C, the 5’ 
and 3’ UTRs of HN mRNA are 81 and 166 nt, respectively. In order to investigate the functions 
of these UTRs, we have used a reverse genetics technique to generate a series of recombinant 
NDVs carrying deletions in the 5’ and 3’ UTRs of the HN mRNA. We have also generated a 
recombinant NDV in which both the 5’ and 3’ UTRs of HN mRNA were replaced by the 
corresponding UTRs of the NP mRNA. The effects of these alterations in viral transcription, 
translation, replication and pathogenesis were examined. Our results showed that mutation of the 
UTRs affected transcription and translation of HN protein, leading to decreased incorporation of 
HN protein into virus particles and reduced pathogenicity.  
 
4.4 Materials and Methods                
4.4.1 Cells and viruses.  DF1 cells (chicken embryo fibroblast cell line) were grown in 
Dulbecco’s minimal essential medium (DMEM) containing 10% fetal bovine serum (FBS) and 
maintained in DMEM with 2% FBS. HEp2 cells (human epidermoid carcinoma cell line) were 
grown in Eagle’s minimal essential medium (MEM) containing 10% FBS and maintained in 
MEM with 2% FBS. A moderately-pathogenic (mesogenic) NDV strain Beaudette C (BC) and 
other recombinant viruses generated from BC virus were grown in 9-day-old embryonated 
specific-pathogen-free (SPF) chicken eggs. The modified vaccinia virus strain Ankara that 
expresses the T7 RNA polymerase (a generous gift from Dr. Bernard Moss, National Institutes 





4.4.2 Construction of NDV cDNAs with altered 5’ and 3’ UTRs in the HN gene.  Full- length 
antigenome cDNA of NDV strain BC was cloned into plasmid pBR322 and designated pBC 
(Krishnamurthy et al. 2000). The 5’ and 3’ UTRs of HN gene in pBC were modified. All 
constructs were confirmed by dideoxynucleotide sequencing. The mutant UTRs included 
deletion of 6 or 78 nt in 5’ UTR; deletion of 6, 24, or 162 nt in 3’ UTR;  double deletions of 78 
nt in 5’ UTR and 162 nt in 3’ UTR; and replacement of HN 5’ and 3’ UTRs with the 
corresponding UTRs of NP mRNA (Fig.4.1). To construct pBC-5UTRΔ1-6, forward primer 
HNGS1F (+) (5’-CTA CGC GTT GTA GAT GAC CAA AGG ACG ATA TAC GGG TAG 
AAG AGA GGC CGC CCC TCA ATT -3’), which contains Mlu I site and 6 nt deletions at the 
5’UTR of HN, and the reverse primer Age I (-) (5’- TTA CCG GTA GCT GTT TTG CCT TGT 
ATC TCA TTG CCA -3’), which contains Age I site, were used to amplify the desired fragment 
on the template full-length pBC. The PCR product was digested with Mlu I and Age I, and then 
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FIG.4.1 Constructs of recombinant viruses containing deletions in the 5’ and 3’ UTRs of HN 
mRNA. 
Solid bars represent HN mRNA of rBC; double lines represent 5’ and 3’ UTR; thin square dots 
represent deletions of UTR; and the single lines represent 5’ and 3’ UTR of NP mRNA. The 
lengths of HN or NP UTR are marked on the top of the bars. Briefly, viruses rBC-5UTRΔ1-6, 
rBC-5UTRΔ76-81, and rBC-5UTRΔ1-78 include 1st to 6th nucleotide deletions, 76th to 81st 




respectively. Viruses rBC-3UTRΔ1-6, rBC-3UTRΔ40-63, rBC-3UTRΔ161-166, and rBC-
3UTRΔ1-162 include 1st to 6th, 40th to 63rd, 161st to 166th, and 1st to 162nd nucleotide deletions in 
the 3’ UTR of HN mRNA, respectively. The virus rBC-5UTRΔ1-78/3UTRΔ1-162 includes 1st 
to 78th nucleotide in 5’UTR of HN and 1st to 162nd nucleotides in 3’ UTR of HN mRNA 
deletions. The virus rBC-NP5UTR/NP3UTR designate that the 5’and 3’ HN UTRs were 





TABLE 4.1 Primers used to construct pBC-5UTRΔ76-81, pBC-3UTRΔ1-6, pBC-3UTRΔ161-
166 and pBC-3UTRΔ40-63 
HNGE3R(-) (5’- TAC AAT GCC ATC TTC CCA GCT CTT TCA TAG -3’)
HNGE3F(+) (5’- AAT CAA ACT GAA TGC CGG TGC GAG CTC GAA TTC -3’)pBC-3UTRΔ 40-63
HNGE2R(-) (5’- ACT ATT GAC AAG ACT TGA TCT GAT CGC ATG AGC -3’)
HNGE2F(+) (5’- ATT AAG AAA AAA TGT AAG TGG CAA TGA GAT ACA AGG CAA AAC -3’)pBC-3UTRΔ 161-166
HNGE1R(-) (5’- CTA ACC AGA CCT GGC TTC TCT AAC CCC ATC -3’)
HNGE1F(+) (5’ - CAA CTA TGA AAG AGC TGG GAA GAT GGC ATT GTA -3’)pBC-3UTRΔ 1-6
HNGS2R(-) (5’ - GGA CTG CTG TCG GTG AAG CGG TAG AAC GGA GGT - 3’)












To construct pBC-5UTRΔ1-78, forward primer HNGS3F(+) (5’ - CTA CGC GTT GTA 
GAT GAC CAA AGG ACG ATA TAC GGG TAG AAG TCA TGG ACC GCG CAG TTA -
3’), which contains Mlu I site and 78 nt deletions at 5’UTR of HN, together with the reverse 
primer Age I (-), was used to amplify the desired fragment on the full-length pBC. The PCR 
product was digested with Mlu I and Age I, and then inserted into pBC. 
To construct pBC-5UTRΔ76-81, pBC-3UTRΔ1-6, pBC-3UTRΔ161-166 and pBC-
3UTRΔ40-63, plasmid pGEM-HN was used as a PCR template. Forward and reverse primers 
were designed to face away from each other and space the required distance apart relative to the 
template (Table 4.1). The primers were phosphorylated with T4 polynucleotide kinase (New 
England, BioLabs), and the plasmid pGEM-HN was then amplified with platinum Pfx DNA 
polymerase (Invitrogen). The PCR products were cloned into plasmid pGEM-HN and sequenced 
to their entirety. Cloned HN genes were digested with Mlu I and Age I, and then inserted into 
full-length pBC.  
To construct pBC-3UTRΔ1-162, forward primer F6202(+) (5’- GTG AAC ACA GAT GAG 
GAA CC -3’), together with reverse primer HNGE4R(-) (5’- TAT TTA CCG GTA GCT GTT 
TTG CCT TGT ATC TCA TTG CCA CTT ACA TTT TTT CTT AAT CGA CTA  ACC -3’), 
which contains Age I site and a deletion of 162 nt at 3’ UTR of HN, was used. The PCR product 
was digested with Mlu I and Age I, and then inserted into pBC. 
To construct pBC-5UTRΔ1-78/3UTRΔ1-162, forward primer HNGS3F(+), which contains 
Mlu I site and a deletion of 78 nt at 5’UTR , together with reverse primer HNGE4R(-) which 




on the template pBC-5UTRΔ1-78. The PCR product was digested with Mlu I and Age I, and 
then cloned into pBC. 
For rBC-NP5UTR/3UTR, both the 5’ and 3’ UTRs of HN were substituted with NP 5’ and 
3’ UTRs. Briefly, replacement of 3’UTR of HN gene with 3’ UTR of NP was performed by PCR 
on the template pBC with the two primers, F- spe-NP3UTR (5’-TTA CTA GTT GAG ATC 
CTC AAA AAT GAT GGG GTT AGA GAA GCC AGG TCT GGT TAG TTG ACA AAA 
CCC AGC TTG CTT CCA CAA AAT CAT CCC AAT ATC CTC ACC CGT AGT CGA CCC 
CTC GA-3’) and R-age-NP3UTR (5’-TTA CCG GTA GCT GTT TTG CCT TGT ATC TCA 
TTG CCA CTT ACA TTT TTT CTT AAT TTC TCC TCG GCT CTG TTT TGA TTG TTA 
GTG AGC CGC ATT GTG CCT GTG GTA CCT AGG GCG TGC G-3’). The PCR product 
was digested with Spe I and Age I, and then cloned into pBC, and named pBC-NP3UTR. 
Replacement of  HN 5UTR with NP 5 UTR was performed by PCR on the template pBC-
NP3UTR with two primers: F-mlu-NP5UTR (5’-CTA CGC GTT GTA GAT GAC CAA AGG 
ACG ATA TAC GGG TAG AAG GTT GTG AAT CTC GAG TGC GAG CCC GAA GCA 
CAA ACT CGA GAA AGC CTT CTG CCA ACA TGG ACC GCG CAG TTA GCC GAG 
TTG CGT TAG AGA ATG ATG AAA GAG AGG CAA AAA ATA CA-3’) and Age I (-). The 
PCR product containing both NP 5’ and 3’ UTRs was then digested with Mlu I and Age I, then 
cloned into pBC, and named pBC-NP5UTR/NP3UTR. All manipulated regions in the NDV 
cDNAs were sequenced to confirm the presence of the desired mutations. 
 
4.4.3 Recovery of recombinant NDVs.  Recombinant NDVs (rNDVs) were recovered by co-
transfection of each mutant full-length plasmid along with support plasmids encoding NP, P, and 




virus (MVA/T7) capable of synthesizing T7 RNA polymerase. Three days after transfection, the 
cell culture supernatant was used to recover the rNDV by either passage in DF1 cells or injection 
into the allantoic cavities of 9-day-old embryonated chicken eggs until the allantoic fluid became 
hemagglutination (HA) positive (Krishnamurthy et al., 2000). 
 
4.4.4 Sequence analysis of modified HN gene UTRs in recombinant NDVs.  Total RNAs were 
isolated 24 h post-infection from virus-infected DF1 cells, using RNeasy Mini Kit (Qiagen) 
according to the manufacturer’s recommendation. Reverse transcription was performed using 
SuperScript II reverse transcriptase (Invitrogen). The positive-sense primer for RT reaction was 
F6202(+). The cDNA products were amplified by PCR, using F6202(+) as a positive-sense 
primer and a negative-sense primer Xba (-) (5’- AGT ACT CCG GTT ATT CTA GAA TTG 
TGG TTG -3’). The modifications in 3’ and 5’ UTRs of HN gene were confirmed by sequencing 
of the RT-PCR products. 
 
4.4.5 Characterization of recombinant NDVs.  The growth kinetics of recombinant mutant 
viruses was evaluated by multiple-step growth assay. DF1 cells in duplicate wells of six-well 
plates were infected with viruses at a multiplicity of infection (M.O.I.) of 0.01. The infected cells 
were maintained with DMEM containing 2% FBS at 370C in 5% CO2. Supernatant samples were 
collected and replaced with an equal volume of fresh medium at 8 h intervals until 64 h post-
infection. The titer of virus in the collected samples was determined by plaque assay. Briefly, 
monolayers of DF1 cells in six-well plates were infected with 0.1 ml of 10-fold diluted virus. One 




CO2. Four days later, the cells were fixed with methanol and stained with crystal violet 
(Krishnamurthy et al., 2000).  
 
4.4.6 Hemagglutination and Neuraminidase assay.    Furthermore, the hemagglutination (HA) 
and neuraminidase (NA) activities of the parental and mutant viruses were compared by HA and 
NA assays following the standard protocols (Alexander, 1989; Huang et al., 2004). 
 Hemagglutination assay (HA) was performed with 1% (v/v) chicken erythrocytes 
(RBCs) according to the standard protocol (Alexander, 1989). Briefly, a serial two fold dilutions 
of 0.05 ml of virus suspension in PBS were made in a plastic V-bottom 96-well plate. Then 0.05 
ml of 1% (v/v) chicken RBCs is dispensed to each well and mix well. The plate was incubated 
on ice for 30 min. HA titer was determined by as the highest serum dilution giving complete red 
cells agglutination.  
A fluorescence based neuraminidase (NA) assay was done as described previously 
(Huang et al., 2004a). Briefly, a serial two fold dilutions of 0.05 ml of virus samples were 
prepared in enzyme buffer (32.5 ml of 0.1 2-N-Morpholinoethanesulfonic acid [MES], pH 6.5 
and 4.0 ml of 0.1 M calcium chloride made up to a final volume of 100 ml with Mili-Q water)) in 
a 96 well plate. Ten ul of 12.5% DMSO was added to each samples and then transferred in 
duplicates to assay plate. The reaction was started by adding 10 ul of enzyme buffer and 30 ul of 
substrate mix per well at 370C for 15 min with shaking. Then the reaction was terminated by 
adding 150 ul of 0.014M sodium hydroxide in 83% (v/v) ethanol. NA activity of the recovered 
viruses was measured by quantifying the 4-methylumbelliferone released from the fluoregenic 





4.4.7 Northern blot hybridization.  DF1 cells in six-well plates were infected with recombinant 
NDVs at a MOI of 5. Twenty-four hours after infection, the total RNAs were isolated from virus-
infected DF1 cells using RNeasy mini Kit (Qiagen). The RNAs were electrophoresed in 
denaturing 1.5% agarose gels containing 0.5 M  formaldehyde, transferred onto nitrocellulose 
membranes, and then hybridized with 32P-labeled double-stranded cDNA probes specific to NDV 
HN, F, L or NP mRNA. The bands corresponding to each mRNA were quantitated by Fuji 
phosphorimager. The 28S and 18S RNAs were used as loading controls.  
 
4.4.8 Western blot analysis.  To examine the expression of HN protein by the recombinant 
NDVs, Western blot assays were performed using a standard protocol (Huang et al., 2004b). 
Total cell lysates were collected from virus-infected DF1 cells after 24 hours of infection. Equal 
amounts of proteins were separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) on 
an 8% gel, and then transferred to a nitrocellulose membrane. The membrane was incubated with 
a monoclonal antibody against the NDV HN protein (a gift from Dr. Ronald Iorio, University of 
Massachusetts Medical School) and a monospecific antibody against the M protein prepared in 
our laboratory. The membrane was washed, and subsequently incubated with horseradish 
peroxidase-conjugated goat anti-mouse or goat anti-chicken immunoglobulin G antibody 
(Kirkegaard & Perry Laboratories, MD). Protein bands were visualized after incubation with 
ECL Western blotting detection reagent (GE Healthcare, UK). The bands corresponding to the 
NDV HN and M proteins were quantitated by ImageJ software. Western blot analyses were 





4.4.9 Analysis of proteins present in purified recombinant NDVs.  Proteins present in purified 
recombinant viruses were examined by 8% SDS-PAGE under reducing conditions (Shirtridge et 
al., 1980).  Briefly, parental and mutant viruses were purified through a 30% sucrose cushion 
centrifuged in the SW28 rotor (Beckman coulter) for 2.5 hours at 20,000 rpm (Peter and 
Robinson, 1965). Purified viruses were dissolved in sterile PBS, and the amounts of total proteins 
were quantified by Micro BCA Protein Assay Reagent Kit (PIERCE). Equal amounts of proteins 
were separated by electrophoresis on an 8% SDS-PAGE gel. The viral protein bands were 
visualized after staining with Coomassie brilliant blue. These experiments were also repeated 
three times to confirm the results. 
 
4.4.10 Evaluation of recombinant virus pathogenicity in chickens.  The pathogenicity of the 
mutant viruses was determined by an internationally-accepted pathogenicity test, intracerebral 
pathogenicity index (ICPI) test in 1-day-old specific pathogen free (SPF) chicks (Yan and Samal, 
2008). Furthermore, the pathogenicity of the parental and mutant viruses (rBC, rBC-5UTRΔ1-78, 
rBC-3UTRΔ1-162 and rBC-5UTRΔ1-78/3UTRΔ1-162) was evaluated in 2-week-old chickens by 
the natural route of infection. Briefly, groups of nine 2-week-old SPF chickens were inoculated 
with 106 PFU of virus per chicken via the oculonasal route. The birds were observed daily for 
clinical symptoms of disease until 7 days post-infection. To determine the replication ability of 
viruses, three birds from each group were euthanized at 3, 5 and 7 days post-infection. Tissue 
samples (brain, lungs, trachea and spleen) were collected, homogenized and titrated by plaque 





4.4.11 Analysis of the antibody response in chickens to mutant viruses.  To examine the 
antibody response in infected chicken, twelve 4-week-old SPF chickens were infected with 
parental and mutant viruses (rBC, rBC-5UTRΔ1-78, rBC-3UTRΔ1-162 and rBC-5UTRΔ1-
78/3UTRΔ1-162) using natural route of infection. After 14 days at infection, serum samples from 
each group (three chickens) were collected. ELISA, virus-neutralization and hemagglutination-
inhibition (HI) tests were performed to determine the antibody level in each chicken. ELISA was 
performed using a commercial kit according to the manufacturer’s recommendation (Infectious 
Newcastle Disease Antibody Test Kit, SYNBIOTICS Corporation, San Diego, CA). Virus-
neutralization and HI tests were performed following the standard procedure (Beard, 1989).  
 
4.4.12 Immunogold electron microscopy.  To examine the amount of HN protein present on the 
surface of mutant viruses, immunogold electron microscopy was performed in a JEM-1200 EX II 
electron microscope using Aurion conventional gold reagents according to the manufacturer’s 
recommendation (AURION, PA). The viruses were purified from infected allantoic fluid by 
sucrose cushion centrifugation and immunogold labeled with monoclonal antibodies against NDV 
HN protein.  
 
4.5 Results 
4.5.1 Rescue of rNDVs with alterations in 5’ and 3’ UTRs of HN gene.  In NDV strain BC, 
the HN mRNA has 81 nt at the 5’ UTR and 166 nt at the 3’ UTR. To determine the role of 5’ 
and 3’ UTRs of HN mRNA in NDV replication and pathogenicity, we made a total of nine 
different alterations in the UTRs of HN gene in a full-length BC antigenomic cDNA clone 




nucleotides deletions were made upstream of HN AUG start codon, and 78 nt deletions were 
made in the 5’ UTR from 1 to 78 nt of HN gene. In the 3’ UTR, six nucleotides deletions were 
made downstream of HN TAG stop codon, six nucleotides deletions were made upstream of HN 
GE, and 24 nt or 162 nt deletions were made in the middle of 3’UTR of HN mRNA. One mutant 
was made containing both 78 nt deletions and 162 nt deletions in the 5’ and 3’ UTRs of HN 
gene, respectively. In addition, one mutant was constructed by substituting HN 5’ and 3’ UTRs 
with NP 5’ and 3’ UTRs, respectively. All modifications were made to follow the “Rule of Six” 
(Calain and Roux, 1993; Kolakofsky et al., 1998; Phillips et al., 1998; and Samal and Collins, 
1996). 
 
4.5.2 HN UTRs are not essential for NDV replication in vitro.  Mutant viruses were 
recovered by reverse genetics technique as described previously (Krishnamurthy et al., 2000). 
The sequences of deletion/modification UTRs were confirmed by RT-PCR and sequencing. 
There were no noticeable differences in the recovery of recombinant viruses from different 
constructs. To examine the replication of rNDVs in vitro, multi-step growth kinetics was 
performed in DF-1 cells. There was no significant difference in growth kinetics between the 
various mutant viruses and the parental virus rBC (Fig.4.2). All mutant viruses and rBC grew to 
a similar titer after 32 h p.i. This result was consistent with the plaque morphology, which did 
not show any difference in size (Fig.4.3), indicating that both 5’ and 3’ UTRs of HN are not 















































FIG.4.2 Kinetics of replication of mutant NDVs in DF1 cells. 
 
DF1 cell monolayers were infected in duplicate with the indicated viruses at an M.O.I. of 0.01 
PFU per cell for 1 h. The cells were washed with DMEM and then covered with DMEM 
containing 2% FBS at 370C. Aliquots of the supernatant medium were taken at 8 h intervals till 
64 h post-infection, replaced with equal volumes of fresh medium, flash-frozen, and analyzed in 
a single plaque assay. (A) Kinetic of replication of parental virus, rBC, and UTR deletion 









FIG.4.3 Plaque morphology of mutant NDVs containing modified HN UTRs. 
Recovered viruses were titrated in duplicated in 6-well plates. Supernatant collected from virus-
inoculated samples was serially diluted, and 0.2 ml of each diluents was added into confluent 
DF1 cells per well. After 1h of adsorption, cells were overlaid with DMEM containing 2% FBS 
and 1% methylcellulose, and incubated at 370C for 4 days. The cells were then fixed with 
methanol and stained with crystal violet. 
 
 
4.5.3 HN mRNA transcription was affected by deletion of HN UTRs.  The level of HN 
mRNA transcription of different UTR deletion viruses was analyzed by Northern blot 




species. The 28S and 18S RNAs were included as control. The ratio of HN to NP mRNA was 
quantified by measuring radioactivity using Fuji phosphorimager. Our results showed that the 
HN to NP mRNA ratios of 5’ UTR complete deletion virus, rBC-5UTRΔ1-78, and the 5’ and 3’ 
UTR complete double- deletion virus, rBC-5UTRΔ1-78/3UTRΔ1-162, were approximately 
20%; and the HN to NP mRNA ratio of 3’ UTR complete deletion virus, rBC-3UTRΔ1-162, was 
approximately 30%; whereas, the HN to NP mRNA ratios of other HN UTR deletion viruses and 
the parental virus, rBC, were approximately 50% (Fig.4.4 B). These data indicated that complete 
deletion of 5’ or 3’ UTR affected HN mRNA transcription. It also indicated that 5’UTR may be 
more sensitive to HN mRNA transcription than 3’UTR, since 5’ UTR showed more effect on 



















































































































FIG.4.4 Northern blot analysis of RNAs synthesized by mutant NDVs with modified 5’ and 3’ 
HN UTR. 
DF1 cells were infected with the indicated viruses (M.O.I. of 5 PFU), incubated for 24 h and 
harvested, and then total intracellular RNAs were extracted. The RNAs were separated by 
electrophoresis in formaldehyde agarose gel, transferred onto nitrocellulose membranes, and 
hybridized with 32P-labeled double-stranded cDNA probes specific to the HN, NP, L, and F  




(C), and L to NP mRNA levels (D). The amounts of HN and NP mRNAs were normalized by 
the amount of 28 S RNA (A).  
Lanes: 1, rBC-5UTRΔ1-6;   2, rBC-5UTRΔ76-81;   3, rBC-5UTRΔ1-78;      4, rBC-3UTRΔ1-6;         
5, rBC-3UTRΔ161-166;  6, rBC-3UTRΔ40-63;     7, rBC-3UTRΔ1-162;        






















 To ascertain the deletion of HN UTRs did not affect transcription of other virus genes, F 
and L mRNAs transcription were also examined following the same procedure. The ratio of F to 
NP mRNA did not show a detectable difference (Fig.4.4 C), indicating that UTRs of HN did not 
affect upstream gene transcription. We also examined the F-HN read-through transcription. The 
results were consistent with the HN mRNA transcription: viruses that had less HN mRNA 
transcription level also showed less F-HN read-through. This suggested that UTRs could also 
affect read-through transcription. Our results did not show any difference in the level of L 
mRNA (Fig.4.4 D), indicating that HN UTRs have no effect on transcription of downstream L 
gene. 
 
4.5.4 Deletions of 5’ and 3’ UTRs of HN mRNA affect its translation and incorporation 
into virus particles.  The HN protein production of HN UTR deletion NDV mutants in cell 
culture was examined by Western blot, using antibodies specific to NDV HN and M proteins. 
The ratios of HN to M protein level were quantified. Our results showed that two mutant viruses, 
rBC-5UTRΔ1-78 and rBC-5UTRΔ1-78/3UTRΔ1-162, showed significantly lower ratios of HN 
to M (5% for both viruses), compared to the parental virus, rBC (50%) (Fig.4.5). The ratios of 
HN to M proteins of other mutant viruses varied between 29% to 44%, compared to that of rBC. 
These results indicated that deletion of 5’ and 3’ UTRs of HN mRNA also affected the 
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FIG.4.5 Protein synthesis in DF1 cells infected with recombinant viruses. 
(A) Western blot of HN and M proteins from parental and HN UTR mutant virus-infected cells. 
DF1 cells were infected at 5 PFU/cell and total proteins were collected at 24 h postinfection. The 
top panel shows HN protein, and the bottom panel shows M protein. (B) Ratios of quantified HN 
protein to M protein levels from wild type rBC and the HN UTR mutant viruses. The mean 
standard deviations in triplicate samples are shown. *P<0.005.      Lanes: 1, rBC;  
2, rBC-5UTRΔ1-6;  3, rBC-5UTRΔ76-81;    4, rBC-5UTRΔ1-78;    5, rBC-3UTRΔ1-6;   
6, rBC-3UTRΔ161-166;  7, rBC-3UTRΔ40-63;   8, rBC-3UTRΔ1-162;   





We then wanted to examine whether lower levels of production of HN proteins affect 
incorporation of HN into the NDV particles. The parental and mutant viruses harvested from 
allantoic fluids were purified through a sucrose cushion. The proteins present in the purified 
viruses were separated on an 8% SDS-PAGE gel. The amount of each virus protein was 
quantified after Coomassie brilliant blue staining. The 5’ UTR complete deletion virus, rBC-
5UTRΔ1-78, and the 5’ and 3’ UTRs double-deletion virus, rBC-5UTRΔ1-78/3UTRΔ1-162, 
showed lower ratios of HN to M proteins (Fig.4.6). However, the ratios of HN to M proteins of 
other deletion mutant viruses were similar to that of the parental virus. The amount of HN 
protein present on the surface of virus particle was further examined by electron microscopy 
using immunogold labeling with HN antibody. Our results confirmed that on complete 5’ UTR 
deletion and 5’ and 3’ UTRs double-deletion viruses, HN protein was present in much less 
quantity on the surfaces of virus particles compared to that of the parental virus, rBC (Fig.4.7). 
These results were consistent with our Western blot analysis, indicating that complete HN 5’ 
UTR deletions drastically affected HN protein expression level, which, in turn, resulted in less 
















FIG.4.6 Incorporation of viral proteins into virus particles. 
Ultra centrifuge-purified viruses from infected allantoic fluids were separated by electrophoresis 
on an 8% SDS-PAGE gel. The gel was then stained with Coomassie brilliant blue. The 
molecular weight and individual viral proteins are indicated.  
Lanes: 1, protein standard;  2, rBC; 3, rBC-5UTRΔ1-6;  4, rBC-5UTRΔ76-81;     
5, rBC-5UTRΔ1-78;    6, rBC-3UTRΔ1-6;  7, rBC-3UTRΔ161-166;  8, rBC-3UTRΔ40-63;    







FIG.4.7 Immunogold electron micrographs of parental and complete 5’ and 3’ UN UTRs 
deletion viruses. 












In order to determine whether lower incorporation of HN protein in rBC-5UTR∆1-78 
and rBC-5UTR∆1-78/3UTR∆1-166 viruses affected the HA activity of the viruses, freshly-
harvested allantoic fluids of parental and mutant viruses were examined simultaneously by HA 
and plaque assays. The PFU to HA ratios of the parental and mutant viruses were determined. 
Our results showed that the complete 5’ UTR deletion and complete 5’ and 3’ UTR double-
deletion viruses had 10- fold lower HA activity compared to their parental virus; whereas, the 
HA activities of other mutant viruses did not show any significant difference compared to their 
parental virus. NA assay also showed that complete 5’ UTR deletion and complete 5’ and 3’ 













FIG.4.8 The neuraminidase (NA) activities of the parental and HN UTR deletion viruses. 
 
The percent NA activity of mutant viruses are compared to the rBC, whose activity was 
considered to be 100%. The NA activity of purified parental and HN UTR deletion viruses was 













4.5.5  The 5’ UTR of HN affects the pathogenicity of NDV.  Our results showed that deletion 
 of either 5’ or 3’ UTR of HN lowered the ICPI values of mutant viruses compared to their 
parental rBC virus (Table 4.2). However, the ICPI values were lowest in the cases of complete 
5’UTR deletion virus rBC-5UTR∆1-78 and complete 5’ and 3’ UTR double-deletion virus rBC-
5UTR∆1-78/3UTR∆1-162. These results indicated that deletions of UTRs of HN gene ultimately 



































aThe ICPI values for velogenic strains approach the maximum score of 2.00, whereas, lentogenic 









We further evaluated the replication abilities of the mutant viruses in 2-week-old 
chickens by inoculating 106 PFU of virus per bird through the natural route of infection. Three 
mutant viruses, which included the two complete 5’ or 3’ UTR deletion viruses (rBC-5UTR∆1-
78 and rBC-3UTR∆1-162) and the complete 5’ and 3’ UTR double-deletion virus (rBC-
5UTR∆1-78 /3UTR∆1-162), along with the parental virus, rBC, were tested in this study. Nine 
birds in each group were inoculated by intranasal and intraocular routes of infection. Three birds 
each were sacrificed on 3, 5 and 7 dpi. Tissue samples (brain, lungs, trachea and spleen) 
collected from each bird were titrated by plaque assay for virus content. Our results showed that 
viruses could not be detected in any of the tissue samples collected from the birds collected at 7 
dpi, suggesting that viruses were probably cleared by the host immune system within 7 days after 
infection. Virus was detected in all of four tissues of all three birds infected with the parental 
rBC virus at 3 and 5 dpi (Table 4.3). All three birds infected with complete 3’ UTR deletion 
virus also showed virus replication in most tissue samples at 3 and 5 dpi (Table 4. 3); whereas, 
only one of the birds infected with complete 5’ UTR deletion virus showed virus replication in 
trachea and spleen at 5 dpi. Similarly, only one of the birds infected with complete 5’ and 3’ 
UTR double-deletion virus showed virus replication in the trachea and spleen at 3 dpi.(Table 
4.3). Our results also showed that the birds infected with complete 5’ UTR deletion virus and 
complete 5’ and 3’ UTR double-deletion virus were either mildly sick or healthy throughout the 
course of the study; whereas, the birds infected with the parental virus and the complete 3’ UTR 
deletion virus exhibited symptoms of sickness and paralysis. These results suggested that 
complete deletion of 5’ UTR of HN highly debilitated the replication ability of NDV in chickens, 





TABLE 4.3. Replication of recombinant viruses in 2-week-old chickens 
Day 3      Day 5
Virus a Brain               Lungs           Trachea       Spleen     Brain               Lungs         Trachea         Spleen
(PFU/g)        ( PFU/g)          (PFU/g)      (PFU/g)            (PFU/g)           (PFU/g)        (PFU/g)       (PFU/g)
rBC (1)                                                            1.5x103               1.6x102                 1.0x104            2.5x102                1.0x103                4.4x102              1.0x104              1.0x103
rBC (2)                                                            2.1x103               7.0x102                 2.4x103          7.5x102                 1.2x103                1.0x103             2.0x103               7.3x102
rBC (3)                                                            1.6x103              2.7x103                  2.4x103           7.0x102                 1.0x103             2.0x103             1.0x104               2.3x102
rBC-5UTRΔ1-78 (1)                                              NDb ND                   ND ND ND ND 1.0x104 8.0x102
rBC-5UTRΔ1-78 (2)                                              ND          ND ND ND ND ND ND ND
rBC-5UTRΔ1-78 (3)                                              ND          ND ND ND ND ND ND ND
rBC-3UTRΔ1-162 (1)                                         3.0x102    ND                7.5x102 ND                  ND 2.0x103 3.0x104 7.0x101
rBC-3UTRΔ1-162 (2)                                           ND            ND 1.2x102 2.0x102 3.0x102 1.0x103 1.0x104 4.3x103
rBC-3UTRΔ1-162 (3)                                         1.2x103 1.5x102 9.0x103 ND              1.2x103 6.0x103 9.0x103 4.4x102
rBC-5UTRΔ1-78/3UTRΔ1-162 (1)                      ND                 ND ND ND ND ND ND ND
rBC-5UTRΔ1-78/3UTRΔ1-162 (2)                      ND               1.5x102 6.3x102 ND                   ND ND ND ND
rBC-5UTRΔ1-78/3UTRΔ1-162 (3)                      ND                 ND ND ND ND ND ND ND
rBC-NP5UTR/NP3UTR (1)                              1.6x103 ND                 1.1x104 ND               1.0x103 ND                ND ND
rBC-NP5UTR/NP3UTR (2)                              8.0x102 5.0x102 1.5x103 2.8x103 6.0x102 3.0x102 1.8x103 ND
rBC-NP5UTR/NP3UTR (3)                              3.3x102 3.3x102 3.5x103 ND              5.0x102 ND                 ND ND  
a Two-week-old chickens in groups of 9 were infected with 106 PFU of each virus per chicken 
by oculonasal route. On days 3, 5, and 7, three chickens per group were sacrificed. Brain, lungs, 
trachea and spleen were collected and virus titers were determined by plaque assay. No virus 
was detected in all the tissues samples from each group on day 7. 
 b Not detected 



























































a Four-week-old chickens in groups of 3 were infected with 106 PFU of each virus per chicken by 
oculonasal route. Serum samples were collected from the infected chickens after 14 days of 
infection.                                                  b S/P ratio: (sample-negative)/(positive-negative) 




We also evaluated the ability of the above mutant viruses to elicit antibody response in 4-
week-old chickens since these mutant viruses produced much less HN proteins. Groups of three 
chickens were infected with 106 PFU of virus per bird through the natural routes of infection. 
Fourteen days after infection, serum samples were collected from each chicken and tested for 
antibody levels by ELISA and virus neutralization tests. Our results showed that chickens 
infected with complete 5’ UTR deletion and complete 5’ and 3’ UTR double-deletion viruses 
elicited significantly less neutralizing antibody response than that of complete 3’ UTR deletion 
and parental rBC viruses (Table 4.4). These results indicated that the lower replication ability of 
complete 5’ UTR and complete 5’ and 3’ UTR double-deletion viruses was probably responsible 
for the induction of lower levels of neutralizing antibody. 
 
4.5.6 Replacement of 5’ and 3’ UTRs of HN with the corresponding UTRs of NP.  To 
determine whether the function of UTRs of HN could be fulfilled by the UTRs of another NDV 
gene, we replaced the UTRs of HN with the corresponding UTRs of NP. The recombinant 
mutant virus rBC-NP5UTR/NP3UTR, whose HN gene contained UTRs of NP in place of its 
own, was rescued and confirmed by RT-PCR and sequencing. Our results showed that the 
growth kinetics of rBC-NP5UTR/NP3UTR virus was similar to that of the parental virus 
(Fig.4.1b). Western blot analysis showed that the HN protein was produced at the same level as 
the parental rBC virus (Fig.4.5). Analysis of the proteins present in the purified virus also 
showed that the same amount of HN protein as the parental virus was incorporated into virus 
particles (Fig.4.6). The pathogenicity studies showed that the virulence of the virus rBC-




at 2-week-old chickens as the parental virus at 3dpi (Table 4.3). These results suggested that the 
UTRs of HN could be replaced with the UTRs of NP without affecting the functions of HN.  
 
4.6 Discussion  
In a paramyxovirus, the sequence composition and length of UTRs vary among the 
different mRNAs. For example, in NDV strain Beaudette C, the 5’ and 3’ UTRs of NP mRNA 
are 56 nt and 200 nt, respectively; whereas, those of HN mRNA are 81 nt and 166 nt, 
respectively. Furthermore, the sequence and length of UTRs for the same mRNA are also 
sometimes not conserved among NDV strains. For example, between NDV strain 99-0868lo 
(Gene Bank Accession: AY935496) and strain Beaudette C, the HN 5’ UTRs are same length, 
but vary in sequence; whereas, the HN 3’ UTRs vary in both sequence and length. Currently, 
functions of 5’ and 3’ UTRs of mRNA in a paramyxovirus life cycle are not well understood. 
In this study, we used reverse genetics to investigate the functions of 5’ and 3’ UTRs of 
HN mRNA of NDV. Since we did not know which regions of the HN UTRs were essential for 
virus replication, several partial and complete deletions of the 5’ and 3’ UTRs were constructed. 
We were able to rescue all mutant viruses carrying deletions in the HN 5’ or 3’ UTR, and one 
more mutant virus in which both HN 5’ and 3’ UTRs were deleted. All the mutant viruses 
exhibited similar multi-step growth curves and plaque sizes in cell culture. These results 
suggested that HN UTRs are nonessential for virus growth in vitro; therefore, it was possible to 
recover recombinant viruses with deletions in the HN UTRs. 
Quantification of the relative ratio of HN/NP mRNA accumulated in parental NDV-
infected cells and the cells infected with NDV mutants indicated that deletion of HN 5’ and 3’ 




accumulations of HN mRNA levels in the case of complete 5’ UTR deletion, complete 3’ UTR 
deletion and complete 5’ and 3’ UTR double-deletion viruses. Quantification of the relative ratio 
of F/NP mRNA levels indicated that deletion of HN UTRs did not affect accumulations of other 
viral mRNAs. In influenza A virus, mutation of nonconserved nucleotides in the 3’ and 5’ UTRs 
of the NA segment was found to decrease levels of both NA antigenome RNA and mRNA 
segments (Zheng et al., 1996). 
Several processes contribute to the overall accumulation of viral mRNAs in infected 
cells, and impairment in any of the processes could lead to a decrease in mRNA level: (i) 
Reduced binding of viral polymerase complex or host factors are involved in transcription of 
viral mRNA. It is possible that the UTRs contain sites essential for binding viral polymerase 
complex or host factors. Loss of these sites due to deletion of UTRs may decrease efficiency of 
viral polymerase or host factors binding to the genome. In fact, computation analysis of HN UTR 
sequences showed activator/repressor binding sites in the 3’ UTR of HN mRNA and viral myb-
like transcription regulators in the 5’ UTR of HN mRNA. (ii) Inefficient transcription terminator 
can cause decreased initiation of the downstream gene (Bousse et al., 2002; Harmon and Wertz, 
2002; Moudy et al., 2003). It is possible that HN UTRs are involved in termination of F mRNA 
transcription, and deletion of these UTRs leads to decreased transcription of HN mRNA. 
However, our Northern blot assays did not show any increase in the level F-HN bicistronic 
mRNA, indicating that HN UTRs did not affect termination of F mRNA synthesis. (iii) One 
possibility we can not discount is that the reduced accumulation of HN mRNA is due to its 
decreased stability, rather than its decreased synthesis. 
Comparison of the relative ratio of HN/M protein present in parental NDV-infected cells 




5’ UTR and complete deletion of HN 5’ and 3’UTRs drastically affected the synthesis of HN 
protein. Since complete deletion of HN 3’UTR did not significantly affect the level of HN 
present in infected cells, the drastic reduction of HN protein observed in the cells infected with 
virus containing complete HN 5’ and 3’ UTRs was most likely due to the complete deletion of 
HN 5’ UTR. Our results suggested that in the virus-infected cells the HN 5’UTR promotes the 
HN protein translation, since the ratio of the HN protein production to the amount of the HN 
mRNA was significantly higher in the absence of the 5’ UTRs. Our results confirm previous 
studies on the functions of the 5’ UTR of F mRNAs of MeV, canine distemper virus and 
rinderpest virus performed using plasmid system (Evans et al., 1990; Hasel et al., 1987) and in 
an avian sarcoma mRNA (Katz et al., 1986), which showed deletion of 5’ UTR can have an 
inhibitory effect on translation. Katz et al. (1986) suggested that a secondary structure predicted 
to form in the 5’ UTR may allow ribosome to avoid scanning through the entire region, and 
perturbation at such a structure may then inhibit translation efficiency. It may be possible that the 
5’ UTR of NDV HN mRNA form a secondary structure necessary for efficient translation, which 
is absent in 5’ UTR deleted viruses.  
 The amount of HN protein present in purified parental and each mutant virus was 
examined. Interestingly, complete HN 5’UTR deletion and complete HN 5’ and 3’ UTR double-
deletion viruses showed significantly lower amounts of HN protein in virus particles, following 
the same level of HN protein present in cells infected with the respective viruses (Figs.4.6 & 
4.7). However, other 5’ and 3’ UTR deletion viruses that showed lower levels of HN protein 
synthesis in infected cells possessed the same amount of HN protein as their parental virus in 
purified particles. One possible explanation for this observation could be that in these viruses, 




virus, the amount of HN was sufficient for required incorporation into viral particles. But, in 
complete HN 5’UTR deletion and complete 5’ and 3’ UTR double-deletion viruses, the amount 
of HN protein synthesis was drastically low, which was below the amount required for full 
incorporation into virus particles. It was noteworthy that decreased incorporation of the HN 
protein did not increase incorporation of the F protein into virus particles, suggesting that F and 
HN proteins have specific anchor sites inside the virus particles and these sites are not 
exchangeable. 
 HN protein of NDV possesses both the hemagglutinin (HA) and neuraminidase (NA) 
activities associated with the virus (Crennell et al., 2000; Sheehan and Iorio, 1992). We 
examined the HA and NA activities of the parental and deletion mutant viruses. Our results 
showed that the complete HN 5’UTR and complete HN 5’ and 3’ UTR double-deletion viruses 
which had lower HN protein in the virus particles also had low HA and NA activities, 
confirming that HN protein is responsible for both HA and NA activities, not other viral proteins. 
 Pathogenicity studies showed that HN UTR deletion NDVs were viable in vivo, but were 
less virulent than parental NDV. The ICPI test results showed that all HN UTR deleted viruses 
were attenuated in 1-day-old chicks. The complete HN 5’ UTR and complete 5’ and 3’ UTR 
double-deletion viruses showed greater levels of attenuation compared to other HN UTR deletion 
viruses. In order to determine the mechanisms responsible for the reduction in virulence of these 
viruses, 2-week-old chickens were inoculated with the mutant viruses by the oculonasal route. 
Interestingly, our research showed that the complete 5’ UTR and complete 5’ and 3’ UTR 
double-deletion viruses, which have low amounts of HN, replicated inefficiently in most of the 
organs tested, compared to their parental virus (Table 4.3). These results suggest that the low 




viruses may not affect the growth of these viruses in vitro, but the low amount of HN affects 
replication of these viruses in most organs in vivo. Thus, the correct amount of HN on the NDV 
particle is essential for replication and pathogenicity of the viruses in its natural host, chickens. 
Furthermore, we examined the antibody response against these mutant viruses in chickens. Four-
week-old chickens were inoculated with the mutant viruses by the oculonasal route, and the 
antibody levels in infected chickens were determined by ELISA, HI and virus neutralization tests 
(Table 4.4). Our results showed that all these deletion mutant viruses (rBC-3UTR∆1-162, rBC-
5UTR∆1-78, and rBC-5UTR∆1-78/3UTR∆1-162), along with the parental virus, rBC, induced 
antibody in all the inoculated chickens, indicating that all mutant viruses were replication-
competent in 4-week-old chickens. However, the mutants rBC-5UTR∆1-78 and rBC-5UTR∆1-
78/3UTR∆1-162 induced lower levels of antibody, compared to their parental virus, rBC. It is 
possible that the inefficient replication of these mutant viruses in chickens was probably 
responsible for the low level of antibody production. The HI antibody titers of these two viruses 
were also lower than that of their parental viruses, suggesting that the lower amounts of HN 
protein present in the virus particles was most likely responsible for the HI titer. 
 In order to determine whether the functions of UTRs of HN gene could be substituted by 
the UTRs of other NDV genes, we constructed a recombinant virus, rBC-NP5UTR/NP3UTR, in 
which both 5’ and 3’ UTRs of HN were replaced with the corresponding UTRs of NP gene. Our 
results showed that the rBC-NP5UTR/NP3UTR virus replicated at the same level as the parental 
virus in vitro. The UTR-replaced virus produced similar level of HN protein in infected cells as 
that of the parental virus (Fig.4.5). Also, a similar amount of HN protein was incorporated into 
the UTR-replaced virus as in the parental virus (Fig.4.6). Furthermore, pathogenicity studies in 




organs as the parental virus (Table 4.3). These results suggest that UTRs can be exchanged 
between NDV mRNAs without affecting the replication of virus in vitro and in vivo. It will be 
interesting to determine whether the UTRs from a heterologous virus mRNA can also be used to 
substitute the functions of UTRs of NDV mRNAs.  
 The data presented in this paper provide insight into the functions of NDV UTRs in 
particular and paramyxoviruses in general. Our results showed that the HN UTRs may not be 
critical for replication in vitro, but are essential for replication and pathogenicity of NDV in vivo, 
and thereby, demonstrate that UTR deletion is a possible strategy for designing live attenuated 
recombinant NDV vaccines. Development of better live attenuated NDV vaccines will be highly 















 Conclusion and Prospects 
 
5.2 Conclusion and Prospects 
 The family Paramyxoviridae includes some important human pathogens, such as mumps 
virus, measles virus and Nipah virus; and some important animal pathogens, such as Rinderpest 
virus, Canine distemper virus, and NDV. NDV is one of the most important animal viruses that 
cause severe economic losses to the poultry industry worldwide. NDV strains vary widely in their 
pathogenicity. Very little is known about the molecular mechanism responsible for the variation 
pathogenicity of NDV. 
 In this study, I applied reverse genetics system that we previously established in our 
laboratory (Krishnamurthy et al., 2000) to evaluate the role of the noncoding regions in NDV 
transcription, replication, and pathogenesis. I show that the pathogenicity of NDV mesogenic 
strain Beaudette C (BC) can be modulated by changing the length of the noncoding regions.  
Recombinant viruses containing extended or shorten of intergenic sequences (IGS) in F-
HN and/or HN-L altered the level of downstream gene transcription, which in turn, changed the 
ratios of the viral transcripts and affected the virulence (Yan and Samal, 2008). I also 
demonstrated that NDV can tolerate an IGS length of at least 365 nt and was stable after five 
passages in chicken embryos (chapter 3). To my knowledge, this is one of the largest IGS in 
Mononagavirales. My study provides an alternative way to reduce virulence of NDV by 




insertion of complete open reading frame into virus genome (Sakai et al., 1999; Bukreyev et al., 
2005).  However, a couple of interesting questions remain to be answered: First, what is the 
longest foreign sequence that can be inserted into NDV IGS without changing its stability? 
Second, can the length of the first three IGSs affect the virulence of NDV? 
 Besides the length of IGS, the length of untranslated regions (UTR) of HN mRNA could 
also alter the pathogenicity of the mesogenic strain BC. As shown in chapter 4, complete deletion 
of HN UTR reduced the transcription and translation levels, leading to attenuation of virulence. 
However, in the current study, I could not exclude the possibility that the reduced HN mRNA 
accumulation is due to reduced transcription or imparity of the mRNA stability in the mutant 
viruses. The study of mRNA stability of the recombinant HN UTR viruses will provide some 
insights into the transcriptional mechanisms of NDV. I also demonstrated that the HN UTRs 
could be replaced by the corresponding UTRs of the NP gene without affecting the function of 
the HN gene (Chapter 4). The more detailed study of replacing UTRs with the heterologous virus 
mRNA UTRs may pave the way towards studying the transcription mechanism of negative-sense 
RNA viruses. For a single-stranded, positive-sense RNA virus, its genome contains a single open 
reading frame encoding a polyprotein which is flanked by 5’ and 3’ UTRs (Tajima et al., 2007; 
Hunziker et al., 2007). The 5’ UTR usually contains an internal ribosome entry site (IRES) that 
direct cap-independent translation of the viral RNA (Rijnbrand et al., 1995; Wang et al., 1993), 
and the 3’ UTR contains essential domains for viral infectivity in vivo (Yanagi et al., 1999; Yi et 
al., 2003). Based on my results on replacement of HN UTRs with corresponding NP UTRs, it 
would be interesting to examine whether the UTRs could be exchanged between negative-sense 




Although vaccines are currently available to provide certain level of protection against 
NDV in poultry, occasional outbreaks of virulent NDV strains have been reported. Moreover, 
depending on the type of NDV vaccine strains used, the environmental conditions, and immune 
system of individual birds, disease signs may occur. This study not only provides basic 
information of NDV pathogenicity but also provides new methods to attenuate the pathogenicity 
of NDV strains by changing the length of noncoding regions, which could be applied for 
development of novel NDV vaccines. 
NDV can be used as an ideal model to study the molecular mechanisms of pathogenesis of 
other paramyxoviruses, since the virulence of NDV strains vary from completely avirulent to 
highly virulent. Moreover, the pathogenesis study of NDV can be directly carried out in its 
natural host, the chicken. Therefore, the detailed study of molecular mechanisms of NDV 
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